| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inhibitory MHC class I receptor activity | 8.74e-10 | 12 | 202 | 6 | GO:0032396 | |
| GeneOntologyMolecularFunction | MHC class I receptor activity | 1.67e-08 | 18 | 202 | 6 | GO:0032393 | |
| GeneOntologyMolecularFunction | IgM binding | 4.43e-08 | 11 | 202 | 5 | GO:0001791 | |
| GeneOntologyMolecularFunction | HLA-A specific inhibitory MHC class I receptor activity | 5.04e-08 | 5 | 202 | 4 | GO:0030107 | |
| GeneOntologyMolecularFunction | HLA-B specific inhibitory MHC class I receptor activity | 1.50e-07 | 6 | 202 | 4 | GO:0030109 | |
| GeneOntologyMolecularFunction | MHC class Ib protein complex binding | 3.47e-07 | 7 | 202 | 4 | GO:0023025 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | LILRB2 DAB2 LILRB1 FASN PTPRD PTPRF PTPRH ROBO3 CNTN2 CNTN4 LILRA1 LILRA2 VWF ITGA8 GRIN2B LRRC4C USP8 NISCH MACF1 PKN2 TNXB | 8.04e-07 | 599 | 202 | 21 | GO:0050839 |
| GeneOntologyMolecularFunction | immunoglobulin binding | 1.50e-06 | 36 | 202 | 6 | GO:0019865 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL6A5 HMCN2 AEBP1 ACAN MXRA5 VWF COL17A1 VWA1 VCAN PRG4 TNXB | 3.51e-06 | 188 | 202 | 11 | GO:0005201 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GP6 ABCA1 LILRB2 LILRB1 CHRNB1 PTPRA HMCN2 PTPRD PTPRF PTPRH ABCC8 PKD1 FGFR3 MERTK GPR132 IL27RA MPL VLDLR LILRA1 LILRA3 LILRA2 NTRK3 PKD2L1 GRIN2B GRM2 CSF1R GPR61 IL21R PLXNA4 GPR45 LILRA4 EPHA5 | 5.98e-06 | 1353 | 202 | 32 | GO:0004888 |
| GeneOntologyMolecularFunction | MHC class I protein binding | 1.63e-05 | 32 | 202 | 5 | GO:0042288 | |
| GeneOntologyMolecularFunction | MHC class Ib protein binding | 1.68e-05 | 16 | 202 | 4 | GO:0023029 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 2.18e-05 | 17 | 202 | 4 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 2.18e-05 | 17 | 202 | 4 | GO:0019198 | |
| GeneOntologyMolecularFunction | MHC class Ib receptor activity | 3.50e-05 | 19 | 202 | 4 | GO:0032394 | |
| GeneOntologyMolecularFunction | immune receptor activity | 4.77e-05 | 165 | 202 | 9 | GO:0140375 | |
| GeneOntologyMolecularFunction | calcium ion binding | MASP1 ENPP3 CDHR1 STAB1 HMCN2 LPCAT2 ACAN PKD2 MMP12 VLDLR PCDHGA9 FAT3 PKD2L1 PCDHA10 LETM1 VCAN NCAN DLL3 MACF1 PROC | 7.73e-05 | 749 | 202 | 20 | GO:0005509 |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 8.52e-05 | 103 | 202 | 7 | GO:0004725 | |
| GeneOntologyMolecularFunction | NAD(P)HX epimerase activity | 1.02e-04 | 2 | 202 | 2 | GO:0052856 | |
| GeneOntologyMolecularFunction | acetyl-CoA carboxylase activity | 1.02e-04 | 2 | 202 | 2 | GO:0003989 | |
| GeneOntologyMolecularFunction | hyaluronic acid binding | 1.98e-04 | 29 | 202 | 4 | GO:0005540 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 2.24e-04 | 85 | 202 | 6 | GO:0038024 | |
| GeneOntologyMolecularFunction | MHC protein binding | 2.99e-04 | 58 | 202 | 5 | GO:0042287 | |
| GeneOntologyMolecularFunction | protein phosphatase 1 binding | 4.16e-04 | 35 | 202 | 4 | GO:0008157 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 5.09e-04 | 65 | 202 | 5 | GO:0004714 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 5.99e-04 | 102 | 202 | 6 | GO:0001540 | |
| GeneOntologyMolecularFunction | very-low-density lipoprotein particle receptor activity | 6.03e-04 | 4 | 202 | 2 | GO:0030229 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 7.68e-04 | 41 | 202 | 4 | GO:0023023 | |
| GeneOntologyMolecularFunction | coreceptor activity | 8.14e-04 | 72 | 202 | 5 | GO:0015026 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.19e-03 | 21 | 202 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | collagen binding | 1.39e-03 | 81 | 202 | 5 | GO:0005518 | |
| GeneOntologyMolecularFunction | CoA carboxylase activity | 1.49e-03 | 6 | 202 | 2 | GO:0016421 | |
| GeneOntologyMolecularFunction | biotin binding | 1.49e-03 | 6 | 202 | 2 | GO:0009374 | |
| GeneOntologyMolecularFunction | phosphatase binding | 1.52e-03 | 264 | 202 | 9 | GO:0019902 | |
| GeneOntologyMolecularFunction | peptide binding | HFE LDLRAP1 HLA-B LILRB2 LILRB1 TOMM40L TPP1 LILRA1 LILRA2 GRIN2B | 1.54e-03 | 318 | 202 | 10 | GO:0042277 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring compression resistance | 1.56e-03 | 23 | 202 | 3 | GO:0030021 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.68e-03 | 268 | 202 | 9 | GO:0005539 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.72e-03 | 85 | 202 | 5 | GO:0019199 | |
| GeneOntologyMolecularFunction | SH2 domain binding | 1.88e-03 | 52 | 202 | 4 | GO:0042169 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-carbon bonds | 2.07e-03 | 7 | 202 | 2 | GO:0016885 | |
| GeneOntologyMolecularFunction | GPI-linked ephrin receptor activity | 2.07e-03 | 7 | 202 | 2 | GO:0005004 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 3.18e-03 | 189 | 202 | 7 | GO:0004721 | |
| GeneOntologyMolecularFunction | cell-cell adhesion mediator activity | 3.38e-03 | 61 | 202 | 4 | GO:0098632 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 3.39e-03 | 30 | 202 | 3 | GO:0004693 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 3.39e-03 | 30 | 202 | 3 | GO:0097472 | |
| GeneOntologyMolecularFunction | amide binding | 3.50e-03 | 299 | 202 | 9 | GO:0033218 | |
| GeneOntologyBiologicalProcess | interleukin-10-mediated signaling pathway | 4.07e-08 | 11 | 205 | 5 | GO:0140105 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | CDHR1 DACT2 DAB2 NCAM1 CUL7 HMCN2 PTPRD PTPRF ATXN2 PTPRS ANAPC2 PTPRQ FGFR3 ROBO3 CNTN2 CAP2 ARAP1 MPL CNTN4 VLDLR NYAP2 STXBP5 FAT3 NTRK3 LRRC4C CSF1R PLXNA4 KIAA1755 MACF1 PRKDC DMTN EPHA5 | 2.87e-07 | 1194 | 205 | 32 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell junction organization | CTTNBP2 LILRB2 CSMD2 CHRNB1 PTPRA HMCN2 PTPRD PTPRF PTPRS ABCC8 ANAPC2 CNTN2 CAP2 CNTN4 VLDLR COL17A1 NTRK3 GRIN2B LRRC4C CSF1R NCAN PLXNA4 MACF1 PKN2 DMTN SEZ6L EPHA5 SEZ6 | 4.36e-07 | 974 | 205 | 28 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of platelet formation | 9.68e-07 | 3 | 205 | 3 | GO:1905219 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | MBD1 CUL7 DCT PTPRA PTPRD PTPRF PTPRS ACAN ABCC8 ANAPC2 FGFR3 NTRK3 UFL1 CSF1R VCAN NCAN DLL3 PLXNA4 MACF1 | 1.02e-06 | 515 | 205 | 19 | GO:0050767 |
| GeneOntologyBiologicalProcess | regulation of cell development | HLA-B LILRB2 MBD1 CUL7 DCT LILRB1 PTPRA PTPRD PTPRF PTPRS ACAN ABCC8 ANAPC2 FGFR3 FOXJ1 MPL LILRA1 LILRA2 NTRK3 UFL1 CSF1R VCAN NCAN DLL3 PLXNA4 MACF1 PRKDC PROC LILRA4 | 1.41e-06 | 1095 | 205 | 29 | GO:0060284 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | CDHR1 NCAM1 CUL7 HMCN2 PTPRD PTPRF PTPRS ANAPC2 PTPRQ FGFR3 ROBO3 CNTN2 CNTN4 VLDLR STXBP5 FAT3 NTRK3 LRRC4C CSF1R PLXNA4 KIAA1755 MACF1 EPHA5 | 1.66e-06 | 748 | 205 | 23 | GO:0048667 |
| GeneOntologyBiologicalProcess | protein dephosphorylation | LILRB2 ANKLE2 LILRB1 PTPRA PTPRD PTPRF PTPRH PTPRS PTPRQ LILRA1 LILRA2 TNS2 VCAN | 1.82e-06 | 256 | 205 | 13 | GO:0006470 |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | CUL7 DCT PTPRA PTPRD PTPRF ACAN ANAPC2 NTRK3 UFL1 CSF1R VCAN NCAN DLL3 PLXNA4 MACF1 | 2.77e-06 | 354 | 205 | 15 | GO:0050769 |
| GeneOntologyBiologicalProcess | regulation of astrocyte differentiation | 4.02e-06 | 43 | 205 | 6 | GO:0048710 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | CDK18 MBD1 CUL7 DCT PTPRA PTPRD PTPRF PTPRS ACAN ABCC8 ANAPC2 FGFR3 NTRK3 UFL1 CSF1R VCAN NCAN DLL3 PLXNA4 MACF1 | 4.58e-06 | 625 | 205 | 20 | GO:0051960 |
| GeneOntologyBiologicalProcess | long-term synaptic depression | 4.62e-06 | 44 | 205 | 6 | GO:0060292 | |
| GeneOntologyBiologicalProcess | synapse organization | CTTNBP2 LILRB2 CSMD2 CHRNB1 HMCN2 PTPRD PTPRF PTPRS ANAPC2 CNTN2 CAP2 CNTN4 VLDLR NTRK3 GRIN2B LRRC4C NCAN PLXNA4 SEZ6L EPHA5 SEZ6 | 5.08e-06 | 685 | 205 | 21 | GO:0050808 |
| GeneOntologyBiologicalProcess | positive regulation of long-term synaptic depression | 8.77e-06 | 14 | 205 | 4 | GO:1900454 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | LILRB2 CUL7 DCT PTPRA PTPRD PTPRF ACAN ANAPC2 MPL NTRK3 UFL1 CSF1R VCAN NCAN DLL3 PLXNA4 MACF1 PRKDC PROC | 1.28e-05 | 614 | 205 | 19 | GO:0010720 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CDHR1 HMCN2 PTPRD PTPRF PTPRS PKD1 ROBO3 CNTN2 CNTN4 PCDHGA9 FAT3 PCDHA10 LRRC4C | 1.61e-05 | 313 | 205 | 13 | GO:0098742 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | NCAM1 CUL7 HMCN2 PTPRD PTPRF ATXN2 PTPRS ANAPC2 FGFR3 ROBO3 CNTN2 CNTN4 VLDLR NYAP2 STXBP5 NTRK3 LRRC4C CSF1R PLXNA4 KIAA1755 MACF1 EPHA5 | 1.71e-05 | 802 | 205 | 22 | GO:0048812 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CDHR1 HMCN2 PTPRF PKD1 ROBO3 CNTN2 CNTN4 PCDHGA9 FAT3 PCDHA10 | 1.85e-05 | 187 | 205 | 10 | GO:0007156 |
| GeneOntologyBiologicalProcess | negative regulation of immune system process | HFE MASP1 HLA-B LILRB2 ENPP3 ADAR LILRB1 PTPRS MERTK CLNK MMP12 IL27RA FOXJ1 LILRA1 LILRA2 UFL1 PRKDC LILRA4 CD276 | 1.88e-05 | 631 | 205 | 19 | GO:0002683 |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | CUL7 DCT PTPRA PTPRD PTPRF ACAN ANAPC2 NTRK3 UFL1 CSF1R VCAN NCAN DLL3 PLXNA4 MACF1 | 2.01e-05 | 418 | 205 | 15 | GO:0051962 |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine dephosphorylation | 2.03e-05 | 34 | 205 | 5 | GO:0035335 | |
| GeneOntologyBiologicalProcess | neuron development | HLA-B KIF26A CDHR1 DAB2 NCAM1 CUL7 HMCN2 PTPRD PTPRF ATXN2 PTPRS ANAPC2 PTPRQ FGFR3 ROBO3 CNTN2 CNTN4 VLDLR NYAP2 STXBP5 FAT3 NTRK3 LRRC4C CSF1R TMEM132E PLXNA4 KIAA1755 CNTN3 MACF1 TNXB EPHA5 SEZ6 | 2.06e-05 | 1463 | 205 | 32 | GO:0048666 |
| GeneOntologyBiologicalProcess | central nervous system development | KIF26A MBD1 NCAM1 ANKLE2 DCT PTPRA ATXN2 PTPRS ACAN TPP1 GLIS2 FGFR3 CNTN2 FOXJ1 CNTN4 VLDLR DMXL2 NTRK3 GRIN2B CSF1R VCAN NCAN DLL3 PLXNA4 PRKDC SEZ6L EPHA5 SEZ6 | 2.20e-05 | 1197 | 205 | 28 | GO:0007417 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | NCAM1 CUL7 HMCN2 PTPRD PTPRF ATXN2 PTPRS ANAPC2 FGFR3 ROBO3 CNTN2 CNTN4 VLDLR NYAP2 STXBP5 NTRK3 LRRC4C CSF1R PLXNA4 KIAA1755 MACF1 EPHA5 | 2.36e-05 | 819 | 205 | 22 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | NCAM1 CUL7 HMCN2 PTPRD PTPRF ATXN2 PTPRS ANAPC2 FGFR3 ROBO3 CNTN2 CNTN4 VLDLR NYAP2 STXBP5 NTRK3 LRRC4C CSF1R PLXNA4 KIAA1755 MACF1 EPHA5 | 2.68e-05 | 826 | 205 | 22 | GO:0048858 |
| GeneOntologyBiologicalProcess | neuron projection development | HLA-B KIF26A DAB2 NCAM1 CUL7 HMCN2 PTPRD PTPRF ATXN2 PTPRS ANAPC2 FGFR3 ROBO3 CNTN2 CNTN4 VLDLR NYAP2 STXBP5 FAT3 NTRK3 LRRC4C CSF1R PLXNA4 KIAA1755 CNTN3 MACF1 TNXB EPHA5 SEZ6 | 2.99e-05 | 1285 | 205 | 29 | GO:0031175 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | LILRB2 NCAM1 LILRB1 PTPRA GRID2IP PTPRD PTPRS ANAPC2 CNTN2 CNTN4 LILRA1 LILRA2 STXBP5 GRIN2B LRRC4C GRM2 USP8 NISCH NCAN | 3.68e-05 | 663 | 205 | 19 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | LILRB2 NCAM1 LILRB1 PTPRA GRID2IP PTPRD PTPRS ANAPC2 CNTN2 CNTN4 LILRA1 LILRA2 STXBP5 GRIN2B LRRC4C GRM2 USP8 NISCH NCAN | 3.76e-05 | 664 | 205 | 19 | GO:0099177 |
| GeneOntologyBiologicalProcess | homeostasis of number of cells | LILRB2 ADAR LILRB1 HEPH ATXN2 GLIS2 MERTK MPL LILRA1 LILRA2 UFL1 CSF1R TNFRSF13C PRKDC DMTN | 4.47e-05 | 448 | 205 | 15 | GO:0048872 |
| GeneOntologyBiologicalProcess | dephosphorylation | LILRB2 ANKLE2 LILRB1 PTPRA PTPRD PTPRF PTPRH PTPRS PTPRQ LILRA1 LILRA2 TNS2 VCAN | 4.69e-05 | 347 | 205 | 13 | GO:0016311 |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | CUL7 PTPRD PTPRF ANAPC2 CNTN2 ARAP1 MPL CSF1R PLXNA4 MACF1 PRKDC DMTN | 5.24e-05 | 302 | 205 | 12 | GO:0022604 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | LILRB2 NCAM1 LILRB1 CHRNB1 PTPRA GRID2IP PTPRD PTPRS ABCC8 ANAPC2 CNTN2 CNTN4 LILRA1 DMXL2 LILRA2 STXBP5 GRIN2B LRRC4C GRM2 USP8 NISCH NCAN SEZ6 | 5.58e-05 | 931 | 205 | 23 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | LILRB2 NCAM1 LILRB1 CHRNB1 PTPRA GRID2IP PTPRD PTPRS ABCC8 ANAPC2 CNTN2 CNTN4 LILRA1 DMXL2 LILRA2 STXBP5 GRIN2B LRRC4C GRM2 USP8 NISCH NCAN SEZ6 | 5.58e-05 | 931 | 205 | 23 | GO:0007268 |
| GeneOntologyBiologicalProcess | negative regulation of astrocyte differentiation | 6.02e-05 | 22 | 205 | 4 | GO:0048712 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | LILRB2 NCAM1 LILRB1 CHRNB1 PTPRA GRID2IP PTPRD PTPRS ABCC8 ANAPC2 CNTN2 CNTN4 LILRA1 DMXL2 LILRA2 STXBP5 GRIN2B LRRC4C GRM2 USP8 NISCH NCAN SEZ6 | 6.35e-05 | 939 | 205 | 23 | GO:0099537 |
| GeneOntologyBiologicalProcess | positive regulation of cell morphogenesis | 6.38e-05 | 69 | 205 | 6 | GO:0010770 | |
| GeneOntologyBiologicalProcess | regulation of long-term synaptic depression | 7.24e-05 | 23 | 205 | 4 | GO:1900452 | |
| GeneOntologyBiologicalProcess | regulation of glial cell differentiation | 8.13e-05 | 104 | 205 | 7 | GO:0045685 | |
| GeneOntologyBiologicalProcess | positive regulation of platelet formation | 9.83e-05 | 2 | 205 | 2 | GO:1905221 | |
| GeneOntologyBiologicalProcess | malonyl-CoA biosynthetic process | 9.83e-05 | 2 | 205 | 2 | GO:2001295 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 1.02e-04 | 75 | 205 | 6 | GO:0050982 | |
| GeneOntologyBiologicalProcess | B cell homeostasis | 1.12e-04 | 48 | 205 | 5 | GO:0001782 | |
| GeneOntologyBiologicalProcess | synaptic signaling | LILRB2 NCAM1 LILRB1 CHRNB1 PTPRA GRID2IP PTPRD PTPRS ABCC8 ANAPC2 CNTN2 CNTN4 LILRA1 DMXL2 LILRA2 STXBP5 GRIN2B LRRC4C GRM2 USP8 NISCH NCAN SEZ6 | 1.13e-04 | 976 | 205 | 23 | GO:0099536 |
| GeneOntologyBiologicalProcess | multicellular organismal-level homeostasis | HFE ACACA ACACB LILRB2 CDHR1 ADAR LILRB1 HEPH ATXN2 TPP1 ABCC8 GLIS2 MERTK CNTN2 MPL LILRA1 LILRA2 TNS2 UFL1 CSF1R ANKRD11 TNFRSF13C PRKDC DMTN | 1.15e-04 | 1043 | 205 | 24 | GO:0048871 |
| GeneOntologyBiologicalProcess | regulation of gliogenesis | 1.37e-04 | 151 | 205 | 8 | GO:0014013 | |
| GeneOntologyBiologicalProcess | protein tetramerization | 1.37e-04 | 113 | 205 | 7 | GO:0051262 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | HLA-B KIF26A DAB2 CUL7 PTPRD PTPRF PTPRS ANAPC2 ROBO3 CNTN2 VLDLR FAT3 NTRK3 LRRC4C PLXNA4 MACF1 SEZ6 | 1.39e-04 | 612 | 205 | 17 | GO:0010975 |
| GeneOntologyBiologicalProcess | negative regulation of immune response | 1.46e-04 | 239 | 205 | 10 | GO:0050777 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission | 1.46e-04 | 80 | 205 | 6 | GO:0050805 | |
| GeneOntologyBiologicalProcess | leukocyte homeostasis | 1.50e-04 | 153 | 205 | 8 | GO:0001776 | |
| GeneOntologyBiologicalProcess | myeloid dendritic cell differentiation | 1.61e-04 | 28 | 205 | 4 | GO:0043011 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 1.62e-04 | 116 | 205 | 7 | GO:0045670 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | LILRB2 DAB2 CUL7 DCT PTPRA PTPRD PTPRF ACAN ANAPC2 FGFR3 FOXJ1 MPL NTRK3 UFL1 CSF1R VCAN NCAN DLL3 PLXNA4 MACF1 PRKDC TNXB SMAD2 PROC CD276 | 1.76e-04 | 1141 | 205 | 25 | GO:0045597 |
| GeneOntologyBiologicalProcess | axonogenesis | NCAM1 HMCN2 PTPRS ANAPC2 FGFR3 ROBO3 CNTN2 CNTN4 STXBP5 NTRK3 LRRC4C CSF1R PLXNA4 KIAA1755 MACF1 EPHA5 | 1.80e-04 | 566 | 205 | 16 | GO:0007409 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | HFE GP6 LILRB2 CDHR1 NCAM1 LILRB1 HMCN2 PTPRD PTPRF PTPRS PKD1 ROBO3 CNTN2 FOXJ1 CNTN4 PCDHGA9 FAT3 ITGA8 PCDHA10 UFL1 LRRC4C TNFRSF13C TNXB CD276 | 1.86e-04 | 1077 | 205 | 24 | GO:0098609 |
| GeneOntologyBiologicalProcess | dendritic cell differentiation | 1.97e-04 | 54 | 205 | 5 | GO:0097028 | |
| GeneOntologyBiologicalProcess | negative regulation of cell development | LILRB2 MBD1 LILRB1 PTPRS ABCC8 FGFR3 FOXJ1 LILRA1 LILRA2 NTRK3 DLL3 LILRA4 | 2.27e-04 | 353 | 205 | 12 | GO:0010721 |
| GeneOntologyBiologicalProcess | axon development | NCAM1 HMCN2 PTPRF PTPRS ANAPC2 FGFR3 ROBO3 CNTN2 CNTN4 STXBP5 NTRK3 LRRC4C CSF1R PLXNA4 KIAA1755 MACF1 EPHA5 | 2.44e-04 | 642 | 205 | 17 | GO:0061564 |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | 2.62e-04 | 166 | 205 | 8 | GO:0002698 | |
| GeneOntologyBiologicalProcess | cellular response to cytokine stimulus | LDLRAP1 ABCA1 LILRB2 YJEFN3 ADAR LILRB1 FASN PTPRF MMP12 IL27RA MPL LILRA1 LILRA3 LILRA2 MUC19 IL18BP CSF1R ADAMTS7 IL21R TNFRSF13C RUFY4 LILRA4 | 2.63e-04 | 967 | 205 | 22 | GO:0071345 |
| GeneOntologyBiologicalProcess | postsynaptic density organization | 2.76e-04 | 58 | 205 | 5 | GO:0097106 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 2.99e-04 | 59 | 205 | 5 | GO:0045671 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | HLA-B KIF26A DAB2 CUL7 PTPRD PTPRF PTPRS ANAPC2 ROBO3 CNTN2 ARAP1 VLDLR FAT3 NTRK3 GRIN2B LRRC4C PLXNA4 MACF1 DMTN SEZ6 | 3.09e-04 | 846 | 205 | 20 | GO:0120035 |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 3.48e-04 | 34 | 205 | 4 | GO:0097107 | |
| GeneOntologyBiologicalProcess | negative regulation of gliogenesis | 3.77e-04 | 62 | 205 | 5 | GO:0014014 | |
| GeneOntologyBiologicalProcess | positive regulation of dephosphorylation | 3.77e-04 | 62 | 205 | 5 | GO:0035306 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | HLA-B KIF26A DAB2 CUL7 PTPRD PTPRF PTPRS ANAPC2 ROBO3 CNTN2 ARAP1 VLDLR FAT3 NTRK3 GRIN2B LRRC4C PLXNA4 MACF1 DMTN SEZ6 | 3.99e-04 | 863 | 205 | 20 | GO:0031344 |
| GeneOntologyBiologicalProcess | protein heterotetramerization | 4.92e-04 | 16 | 205 | 3 | GO:0051290 | |
| GeneOntologyBiologicalProcess | regulation of dendritic cell differentiation | 4.92e-04 | 16 | 205 | 3 | GO:2001198 | |
| GeneOntologyBiologicalProcess | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 5.05e-04 | 66 | 205 | 5 | GO:0002823 | |
| GeneOntologyBiologicalProcess | regulation of neuroblast proliferation | 5.41e-04 | 67 | 205 | 5 | GO:1902692 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | CUL7 YJEFN3 STAB1 PTPRD PTPRF PTPRS ABCC8 ANAPC2 NAXE CNTN2 ARAP1 FOXJ1 MPL MAGED1 NTRK3 HTATIP2 LRRC4C CSF1R PLXNA4 TNFRSF13C MACF1 PRKDC DMTN | 5.47e-04 | 1090 | 205 | 23 | GO:0022603 |
| GeneOntologyBiologicalProcess | negative regulation of glial cell differentiation | 5.94e-04 | 39 | 205 | 4 | GO:0045686 | |
| GeneOntologyBiologicalProcess | astrocyte differentiation | 6.37e-04 | 105 | 205 | 6 | GO:0048708 | |
| GeneOntologyBiologicalProcess | cytokine-mediated signaling pathway | LILRB2 ADAR LILRB1 PTPRF MMP12 IL27RA MPL LILRA1 LILRA3 LILRA2 MUC19 CSF1R IL21R TNFRSF13C LILRA4 | 6.85e-04 | 577 | 205 | 15 | GO:0019221 |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte activation | 6.90e-04 | 240 | 205 | 9 | GO:0002695 | |
| GeneOntologyBiologicalProcess | negative regulation of adaptive immune response | 7.06e-04 | 71 | 205 | 5 | GO:0002820 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization organization | 7.06e-04 | 71 | 205 | 5 | GO:0099084 | |
| GeneOntologyBiologicalProcess | dendrite self-avoidance | 7.07e-04 | 18 | 205 | 3 | GO:0070593 | |
| GeneOntologyBiologicalProcess | regulation of synaptic plasticity | LILRB2 LILRB1 GRID2IP ANAPC2 CNTN2 CNTN4 LILRA1 LILRA2 GRIN2B GRM2 | 7.30e-04 | 293 | 205 | 10 | GO:0048167 |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | HFE HLA-B LILRB2 LILRB1 IL27RA FOXJ1 MPL LILRA1 LILRA2 UFL1 IL18BP IL21R TNFRSF13C | 7.58e-04 | 462 | 205 | 13 | GO:0002460 |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 7.68e-04 | 150 | 205 | 7 | GO:0050773 | |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 7.89e-04 | 42 | 205 | 4 | GO:0099560 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | HFE LILRB2 ENPP3 MBD1 YJEFN3 LILRB1 STAB1 ATXN2 PTPRS ABCC8 FGFR3 MERTK CLNK NAXE IL27RA FOXJ1 LILRA1 LILRA2 NTRK3 MUC16 ISX UFL1 ADAMTS7 DLL3 PRG4 PROC LILRA4 CD276 | 8.31e-04 | 1488 | 205 | 28 | GO:0051241 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | DAB2 PTPRA PKD1 MERTK MMP12 CNTN2 VWF COL17A1 ITGA8 MACF1 TNXB DMTN | 8.59e-04 | 410 | 205 | 12 | GO:0031589 |
| GeneOntologyBiologicalProcess | positive regulation of neuroblast proliferation | 9.42e-04 | 44 | 205 | 4 | GO:0002052 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 9.42e-04 | 44 | 205 | 4 | GO:0098698 | |
| GeneOntologyBiologicalProcess | monocyte homeostasis | 9.64e-04 | 5 | 205 | 2 | GO:0035702 | |
| GeneOntologyBiologicalProcess | Fc receptor mediated inhibitory signaling pathway | 9.64e-04 | 5 | 205 | 2 | GO:0002774 | |
| GeneOntologyBiologicalProcess | negative regulation of toll-like receptor 9 signaling pathway | 9.64e-04 | 5 | 205 | 2 | GO:0034164 | |
| GeneOntologyBiologicalProcess | protein homotetramerization | 1.02e-03 | 77 | 205 | 5 | GO:0051289 | |
| GeneOntologyBiologicalProcess | myeloid dendritic cell activation | 1.12e-03 | 46 | 205 | 4 | GO:0001773 | |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 1.12e-03 | 46 | 205 | 4 | GO:1904861 | |
| GeneOntologyBiologicalProcess | hemopoiesis | HLA-B LILRB2 DACT2 DAB2 YJEFN3 ADAR LILRB1 HEPH FASN SAMD9L PTPRQ FGFR3 MERTK FOXJ1 MPL LILRA1 LILRA2 MUC19 UFL1 CSF1R PRKDC PRG4 DMTN LILRA4 | 1.14e-03 | 1223 | 205 | 24 | GO:0030097 |
| GeneOntologyBiologicalProcess | response to cytokine | LDLRAP1 ABCA1 LILRB2 YJEFN3 ADAR LILRB1 FASN PTPRF MMP12 IL27RA MPL LILRA1 LILRA3 LILRA2 MUC19 IL18BP CSF1R ADAMTS7 IL21R TNFRSF13C RUFY4 LILRA4 | 1.19e-03 | 1083 | 205 | 22 | GO:0034097 |
| GeneOntologyBiologicalProcess | postsynapse organization | LILRB2 CSMD2 CHRNB1 PTPRD PTPRF PTPRS NTRK3 GRIN2B NCAN EPHA5 | 1.20e-03 | 313 | 205 | 10 | GO:0099173 |
| GeneOntologyBiologicalProcess | osteoclast differentiation | 1.20e-03 | 162 | 205 | 7 | GO:0030316 | |
| GeneOntologyBiologicalProcess | regulation of immune response | HFE GP6 MASP1 HLA-B LILRB2 ENPP3 ADAR LILRB1 PTPRD PTPRS CLNK MMP12 IL27RA FOXJ1 LILRA1 LILRA3 LILRA2 UFL1 TNFRSF13C PRKDC LILRA4 CD276 | 1.21e-03 | 1085 | 205 | 22 | GO:0050776 |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte activation | 1.27e-03 | 211 | 205 | 8 | GO:0051250 | |
| GeneOntologyBiologicalProcess | kidney development | DACT2 GLIS2 PKD1 PKD2 CC2D2A TIMELESS MAGED1 ITGA8 TNS2 IRX1 SMAD2 | 1.29e-03 | 372 | 205 | 11 | GO:0001822 |
| GeneOntologyCellularComponent | Fc-epsilon receptor I complex | 1.03e-08 | 9 | 204 | 5 | GO:0032998 | |
| GeneOntologyCellularComponent | Fc receptor complex | 6.31e-08 | 12 | 204 | 5 | GO:0032997 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.24e-06 | 109 | 204 | 9 | GO:0005796 | |
| GeneOntologyCellularComponent | side of membrane | HFE LDLRAP1 ABCA1 HLA-B LILRB2 ENPP3 NCAM1 LILRB1 PKD2 FGFR3 CNTN2 IL27RA MPL CNTN4 LILRA1 LILRA2 VWF NOA1 ITGA8 MUC16 IL21R TNFRSF13C CNTN3 EPHA5 CD276 | 1.54e-06 | 875 | 204 | 25 | GO:0098552 |
| GeneOntologyCellularComponent | external side of plasma membrane | HFE ABCA1 HLA-B LILRB2 ENPP3 NCAM1 LILRB1 IL27RA MPL LILRA1 LILRA2 VWF ITGA8 MUC16 IL21R TNFRSF13C EPHA5 CD276 | 3.65e-06 | 519 | 204 | 18 | GO:0009897 |
| GeneOntologyCellularComponent | cell surface | HFE GP6 ABCA1 HLA-B LILRB2 ENPP3 NCAM1 LILRB1 PKD1 FGFR3 CNTN2 IL27RA MPL VLDLR LILRA1 LILRA2 VWF ITGA8 MUC16 PKD2L1 GRIN2B CSF1R ADAMTS7 VCAN IL21R TNFRSF13C EPHA5 CD276 | 3.96e-06 | 1111 | 204 | 28 | GO:0009986 |
| GeneOntologyCellularComponent | receptor complex | HFE CHRNB1 PTPRA PTPRQ FGFR3 MERTK IL27RA VLDLR STXBP5 NTRK3 ITGA8 PKD2L1 GRIN2B CSF1R GPR61 PLXNA4 EPHA5 | 5.95e-05 | 581 | 204 | 17 | GO:0043235 |
| GeneOntologyCellularComponent | synaptic membrane | NCAM1 CSMD2 CHRNB1 PTPRA GRID2IP PTPRD PTPRF PTPRS SCN10A CNTN2 STXBP5 NTRK3 ITGA8 GRIN2B LRRC4C GRM2 SEZ6L | 6.21e-05 | 583 | 204 | 17 | GO:0097060 |
| GeneOntologyCellularComponent | polycystin complex | 9.48e-05 | 2 | 204 | 2 | GO:0002133 | |
| GeneOntologyCellularComponent | perineuronal net | 1.04e-04 | 10 | 204 | 3 | GO:0072534 | |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 1.43e-04 | 11 | 204 | 3 | GO:0098966 | |
| GeneOntologyCellularComponent | postsynaptic membrane | NCAM1 CSMD2 CHRNB1 GRID2IP PTPRF PTPRS CNTN2 NTRK3 ITGA8 GRIN2B LRRC4C GRM2 SEZ6L | 1.83e-04 | 405 | 204 | 13 | GO:0045211 |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 2.44e-04 | 13 | 204 | 3 | GO:0099535 | |
| GeneOntologyCellularComponent | extracellular matrix | NCAM1 COL6A5 HMCN2 AEBP1 ACAN MMP12 MXRA5 VWF COL17A1 MUC5B VWA1 OVGP1 ADAMTS7 VCAN NCAN PRG4 TNXB | 2.54e-04 | 656 | 204 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | NCAM1 COL6A5 HMCN2 AEBP1 ACAN MMP12 MXRA5 VWF COL17A1 MUC5B VWA1 OVGP1 ADAMTS7 VCAN NCAN PRG4 TNXB | 2.63e-04 | 658 | 204 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | neuron to neuron synapse | CSMD2 GRID2IP PTPRD PTPRF PTPRS CAP2 STXBP5 ITGA8 GRIN2B LRRC4C USP8 PLXNA4 MACF1 DMTN | 6.52e-04 | 523 | 204 | 14 | GO:0098984 |
| GeneOntologyCellularComponent | non-motile cilium | 7.02e-04 | 196 | 204 | 8 | GO:0097730 | |
| GeneOntologyCellularComponent | glutamatergic synapse | CTTNBP2 NCAM1 CSMD2 GRID2IP PTPRD PTPRS ACAN SCN10A VLDLR NTRK3 ITGA8 GRIN2B LRRC4C GRM2 USP8 NCAN PLXNA4 SEZ6L | 1.13e-03 | 817 | 204 | 18 | GO:0098978 |
| MousePheno | abnormal response to transplant | 6.35e-07 | 64 | 160 | 8 | MP:0005671 | |
| MousePheno | polyhydramnios | 1.47e-06 | 3 | 160 | 3 | MP:0004020 | |
| MousePheno | decreased length of allograft survival | 1.99e-06 | 9 | 160 | 4 | MP:0004752 | |
| MousePheno | abnormal visual cortex morphology | 2.70e-05 | 16 | 160 | 4 | MP:0000805 | |
| MousePheno | abnormal occipital lobe morphology | 4.46e-05 | 18 | 160 | 4 | MP:0000804 | |
| MousePheno | abnormal dendritic cell differentiation | 6.94e-05 | 20 | 160 | 4 | MP:0008115 | |
| MousePheno | abnormal T-helper 2 physiology | 1.15e-04 | 67 | 160 | 6 | MP:0005466 | |
| MousePheno | premature sphenooccipital synchondrosis closure | 1.30e-04 | 2 | 160 | 2 | MP:0030446 | |
| Domain | Ig-like_fold | HFE GP6 MYLK MYOM1 HLA-B LILRB2 SPEG NCAM1 LILRB1 HMCN2 PTPRD PTPRF PTPRH PTPRS FNDC9 FGFR3 ROBO3 MERTK CNTN2 IL27RA MPL CNTN4 LILRA1 LILRA3 LILRA2 MXRA5 NTRK3 IL18BP VWA1 LRRC4C CSF1R VCAN NCAN IL21R PLXNA4 CNTN3 TNXB LILRA4 EPHA5 CD276 | 2.02e-18 | 706 | 198 | 40 | IPR013783 |
| Domain | IGc2 | GP6 MYLK MYOM1 SPEG NCAM1 LILRB1 HMCN2 PTPRD PTPRF PTPRS FGFR3 ROBO3 CNTN2 CNTN4 LILRA1 LILRA3 LILRA2 MXRA5 LRRC4C CSF1R CNTN3 LILRA4 CD276 | 6.55e-16 | 235 | 198 | 23 | SM00408 |
| Domain | Ig_sub2 | GP6 MYLK MYOM1 SPEG NCAM1 LILRB1 HMCN2 PTPRD PTPRF PTPRS FGFR3 ROBO3 CNTN2 CNTN4 LILRA1 LILRA3 LILRA2 MXRA5 LRRC4C CSF1R CNTN3 LILRA4 CD276 | 6.55e-16 | 235 | 198 | 23 | IPR003598 |
| Domain | IG_LIKE | HFE GP6 MYLK MYOM1 HLA-B LILRB2 SPEG NCAM1 LILRB1 HMCN2 PTPRD PTPRF PTPRS FGFR3 ROBO3 MERTK CNTN2 CNTN4 LILRA1 LILRA3 LILRA2 MXRA5 NTRK3 IL18BP LRRC4C CSF1R VCAN NCAN CNTN3 LILRA4 CD276 | 1.12e-15 | 491 | 198 | 31 | PS50835 |
| Domain | Ig-like_dom | HFE GP6 MYLK MYOM1 HLA-B LILRB2 SPEG NCAM1 LILRB1 HMCN2 PTPRD PTPRF PTPRS FGFR3 ROBO3 MERTK CNTN2 CNTN4 LILRA1 LILRA3 LILRA2 MXRA5 NTRK3 IL18BP LRRC4C CSF1R VCAN NCAN CNTN3 LILRA4 CD276 | 2.18e-15 | 503 | 198 | 31 | IPR007110 |
| Domain | - | HFE GP6 MYLK MYOM1 HLA-B SPEG NCAM1 LILRB1 PTPRD PTPRF PTPRS FGFR3 ROBO3 MERTK CNTN2 IL27RA MPL CNTN4 LILRA1 LILRA3 LILRA2 MXRA5 NTRK3 VWA1 LRRC4C CSF1R VCAN NCAN IL21R PLXNA4 CNTN3 TNXB LILRA4 EPHA5 CD276 | 3.11e-15 | 663 | 198 | 35 | 2.60.40.10 |
| Domain | IG | GP6 MYLK MYOM1 LILRB2 SPEG NCAM1 LILRB1 HMCN2 PTPRD PTPRF PTPRS FGFR3 ROBO3 MERTK CNTN2 CNTN4 LILRA1 LILRA3 LILRA2 MXRA5 NTRK3 LRRC4C CSF1R VCAN NCAN CNTN3 LILRA4 CD276 | 8.40e-15 | 421 | 198 | 28 | SM00409 |
| Domain | Ig_sub | GP6 MYLK MYOM1 LILRB2 SPEG NCAM1 LILRB1 HMCN2 PTPRD PTPRF PTPRS FGFR3 ROBO3 MERTK CNTN2 CNTN4 LILRA1 LILRA3 LILRA2 MXRA5 NTRK3 LRRC4C CSF1R VCAN NCAN CNTN3 LILRA4 CD276 | 8.40e-15 | 421 | 198 | 28 | IPR003599 |
| Domain | FN3 | MYLK MYOM1 SPEG NCAM1 PTPRD PTPRF PTPRH PTPRS FNDC9 ROBO3 MERTK CNTN2 IL27RA MPL CNTN4 VWA1 IL21R CNTN3 TNXB EPHA5 | 3.40e-14 | 199 | 198 | 20 | PS50853 |
| Domain | FN3_dom | MYLK MYOM1 SPEG NCAM1 PTPRD PTPRF PTPRH PTPRS FNDC9 ROBO3 MERTK CNTN2 IL27RA MPL CNTN4 VWA1 IL21R CNTN3 TNXB EPHA5 | 8.67e-14 | 209 | 198 | 20 | IPR003961 |
| Domain | FN3 | MYLK MYOM1 SPEG NCAM1 PTPRD PTPRF PTPRH PTPRS ROBO3 MERTK CNTN2 IL27RA MPL CNTN4 VWA1 IL21R CNTN3 TNXB EPHA5 | 1.03e-13 | 185 | 198 | 19 | SM00060 |
| Domain | fn3 | MYLK MYOM1 SPEG NCAM1 PTPRD PTPRF PTPRH PTPRS ROBO3 MERTK CNTN2 IL27RA MPL CNTN4 VWA1 CNTN3 TNXB EPHA5 | 1.20e-13 | 162 | 198 | 18 | PF00041 |
| Domain | ig | GP6 MYOM1 NCAM1 LILRB1 PTPRD PTPRS FGFR3 MERTK CNTN2 CNTN4 LILRA1 LILRA3 LILRA2 NTRK3 CSF1R CNTN3 LILRA4 CD276 | 1.89e-12 | 190 | 198 | 18 | PF00047 |
| Domain | Immunoglobulin | GP6 MYOM1 NCAM1 LILRB1 PTPRD PTPRS FGFR3 MERTK CNTN2 CNTN4 LILRA1 LILRA3 LILRA2 NTRK3 CSF1R CNTN3 LILRA4 CD276 | 1.89e-12 | 190 | 198 | 18 | IPR013151 |
| Domain | Ig_I-set | MYLK MYOM1 SPEG NCAM1 HMCN2 PTPRD PTPRF PTPRS FGFR3 ROBO3 MERTK CNTN2 CNTN4 MXRA5 NTRK3 LRRC4C CNTN3 | 2.00e-11 | 190 | 198 | 17 | IPR013098 |
| Domain | I-set | MYLK MYOM1 SPEG NCAM1 HMCN2 PTPRD PTPRF PTPRS FGFR3 ROBO3 MERTK CNTN2 CNTN4 MXRA5 NTRK3 LRRC4C CNTN3 | 2.00e-11 | 190 | 198 | 17 | PF07679 |
| Domain | A1B_glyco/leuk_Ig-like_rcpt | 1.81e-07 | 6 | 198 | 4 | IPR016332 | |
| Domain | EGF_CA | 6.13e-06 | 122 | 198 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 7.00e-06 | 124 | 198 | 9 | IPR001881 | |
| Domain | Sushi | 1.79e-05 | 52 | 198 | 6 | PF00084 | |
| Domain | CCP | 2.23e-05 | 54 | 198 | 6 | SM00032 | |
| Domain | SUSHI | 2.75e-05 | 56 | 198 | 6 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 3.05e-05 | 57 | 198 | 6 | IPR000436 | |
| Domain | PTPc | 3.67e-05 | 36 | 198 | 5 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 5.47e-05 | 39 | 198 | 5 | PS50055 | |
| Domain | PTPase_domain | 7.00e-05 | 41 | 198 | 5 | IPR000242 | |
| Domain | Y_phosphatase | 7.00e-05 | 41 | 198 | 5 | PF00102 | |
| Domain | EGF_Ca-bd_CS | 7.77e-05 | 97 | 198 | 7 | IPR018097 | |
| Domain | EGF_CA | 8.84e-05 | 99 | 198 | 7 | PS01187 | |
| Domain | ASX_HYDROXYL | 9.43e-05 | 100 | 198 | 7 | PS00010 | |
| Domain | EGF-like_CS | 1.12e-04 | 261 | 198 | 11 | IPR013032 | |
| Domain | ACC_central | 1.12e-04 | 2 | 198 | 2 | PF08326 | |
| Domain | AcCoA_COase_cen | 1.12e-04 | 2 | 198 | 2 | IPR013537 | |
| Domain | YJEFN_prot_eukaryotes | 1.12e-04 | 2 | 198 | 2 | IPR032976 | |
| Domain | Ig_2 | 1.24e-04 | 73 | 198 | 6 | PF13895 | |
| Domain | EGF_2 | 1.28e-04 | 265 | 198 | 11 | PS01186 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.36e-04 | 106 | 198 | 7 | IPR000152 | |
| Domain | PKD_channel | 1.82e-04 | 11 | 198 | 3 | PF08016 | |
| Domain | PKD1_2_channel | 1.82e-04 | 11 | 198 | 3 | IPR013122 | |
| Domain | EGF_3 | 2.12e-04 | 235 | 198 | 10 | PS50026 | |
| Domain | C8 | 2.41e-04 | 12 | 198 | 3 | PF08742 | |
| Domain | TIL | 2.41e-04 | 12 | 198 | 3 | PF01826 | |
| Domain | Link_dom | 3.10e-04 | 13 | 198 | 3 | IPR000538 | |
| Domain | Xlink | 3.10e-04 | 13 | 198 | 3 | PF00193 | |
| Domain | LINK_2 | 3.10e-04 | 13 | 198 | 3 | PS50963 | |
| Domain | LINK | 3.10e-04 | 13 | 198 | 3 | SM00445 | |
| Domain | Unchr_dom_Cys-rich | 3.10e-04 | 13 | 198 | 3 | IPR014853 | |
| Domain | C8 | 3.10e-04 | 13 | 198 | 3 | SM00832 | |
| Domain | LINK_1 | 3.10e-04 | 13 | 198 | 3 | PS01241 | |
| Domain | YjeF_N | 3.33e-04 | 3 | 198 | 2 | PF03853 | |
| Domain | YJEF_N | 3.33e-04 | 3 | 198 | 2 | PS51385 | |
| Domain | - | 3.33e-04 | 3 | 198 | 2 | 3.40.50.10260 | |
| Domain | YjeF_N_dom | 3.33e-04 | 3 | 198 | 2 | IPR004443 | |
| Domain | EGF-like_dom | 3.36e-04 | 249 | 198 | 10 | IPR000742 | |
| Domain | TIL_dom | 3.92e-04 | 14 | 198 | 3 | IPR002919 | |
| Domain | EGF | 3.95e-04 | 126 | 198 | 7 | PF00008 | |
| Domain | EGF_1 | 4.06e-04 | 255 | 198 | 10 | PS00022 | |
| Domain | VWF_type-D | 5.94e-04 | 16 | 198 | 3 | IPR001846 | |
| Domain | VWFD | 5.94e-04 | 16 | 198 | 3 | PS51233 | |
| Domain | VWD | 5.94e-04 | 16 | 198 | 3 | SM00216 | |
| Domain | VWD | 5.94e-04 | 16 | 198 | 3 | PF00094 | |
| Domain | Carboxyl_trans | 6.62e-04 | 4 | 198 | 2 | PF01039 | |
| Domain | COA_CT_CTER | 6.62e-04 | 4 | 198 | 2 | PS50989 | |
| Domain | COA_CT_NTER | 6.62e-04 | 4 | 198 | 2 | PS50980 | |
| Domain | PC1 | 6.62e-04 | 4 | 198 | 2 | IPR000434 | |
| Domain | COA_CT_N | 6.62e-04 | 4 | 198 | 2 | IPR011762 | |
| Domain | COA_CT_C | 6.62e-04 | 4 | 198 | 2 | IPR011763 | |
| Domain | Carboxyl_trans | 6.62e-04 | 4 | 198 | 2 | IPR000022 | |
| Domain | CTCK_1 | 8.51e-04 | 18 | 198 | 3 | PS01185 | |
| Domain | VWC_out | 1.00e-03 | 19 | 198 | 3 | SM00215 | |
| Domain | Tyr_Pase_AS | 1.07e-03 | 73 | 198 | 5 | IPR016130 | |
| Domain | Biotin_BS | 1.09e-03 | 5 | 198 | 2 | IPR001882 | |
| Domain | Biotin_COase_C | 1.09e-03 | 5 | 198 | 2 | IPR005482 | |
| Domain | BC | 1.09e-03 | 5 | 198 | 2 | PS50979 | |
| Domain | PKD_2 | 1.09e-03 | 5 | 198 | 2 | IPR003915 | |
| Domain | Biotin_carb_C | 1.09e-03 | 5 | 198 | 2 | SM00878 | |
| Domain | Biotin_carb_C | 1.09e-03 | 5 | 198 | 2 | PF02785 | |
| Domain | Biotin_carboxylation_dom | 1.09e-03 | 5 | 198 | 2 | IPR011764 | |
| Domain | CPSASE_1 | 1.09e-03 | 5 | 198 | 2 | PS00866 | |
| Domain | BIOTIN | 1.09e-03 | 5 | 198 | 2 | PS00188 | |
| Domain | CT | 1.56e-03 | 22 | 198 | 3 | SM00041 | |
| Domain | Rudment_hybrid_motif | 1.63e-03 | 6 | 198 | 2 | IPR011054 | |
| Domain | CPSASE_2 | 1.63e-03 | 6 | 198 | 2 | PS00867 | |
| Domain | CUB | 1.79e-03 | 49 | 198 | 4 | PF00431 | |
| Domain | CUB | 1.93e-03 | 50 | 198 | 4 | SM00042 | |
| Domain | TYR_PHOSPHATASE_1 | 2.21e-03 | 86 | 198 | 5 | PS00383 | |
| Domain | - | 2.23e-03 | 52 | 198 | 4 | 2.60.120.290 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 2.27e-03 | 7 | 198 | 2 | IPR005479 | |
| Domain | BC-like_N | 2.27e-03 | 7 | 198 | 2 | IPR005481 | |
| Domain | CPSase_L_D2 | 2.27e-03 | 7 | 198 | 2 | PF02786 | |
| Domain | Biotin_carb_N | 2.27e-03 | 7 | 198 | 2 | PF00289 | |
| Domain | Cys_knot_C | 2.27e-03 | 25 | 198 | 3 | IPR006207 | |
| Domain | CTCK_2 | 2.27e-03 | 25 | 198 | 3 | PS01225 | |
| Domain | TYR_PHOSPHATASE_dom | 2.33e-03 | 87 | 198 | 5 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 2.33e-03 | 87 | 198 | 5 | PS50056 | |
| Domain | CUB | 2.39e-03 | 53 | 198 | 4 | PS01180 | |
| Domain | Tyr_kinase_cat_dom | 2.45e-03 | 88 | 198 | 5 | IPR020635 | |
| Domain | TyrKc | 2.45e-03 | 88 | 198 | 5 | SM00219 | |
| Domain | Protein_kinase_ATP_BS | CDK18 MYLK CDK15 SPEG FGFR3 MERTK NTRK3 CSF1R PKN2 CDK2 EPHA5 | 2.46e-03 | 379 | 198 | 11 | IPR017441 |
| Domain | - | 2.97e-03 | 92 | 198 | 5 | 3.90.190.10 | |
| Pathway | WP_SPINAL_CORD_INJURY | 1.59e-07 | 108 | 145 | 10 | MM15954 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.08e-06 | 76 | 145 | 8 | M27219 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.91e-06 | 21 | 145 | 5 | MM15706 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.66e-05 | 143 | 145 | 9 | M27275 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 1.78e-05 | 16 | 145 | 4 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 2.30e-05 | 17 | 145 | 4 | M27412 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 4.58e-05 | 20 | 145 | 4 | M27290 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 4.58e-05 | 20 | 145 | 4 | MM14991 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 5.61e-05 | 21 | 145 | 4 | M27736 | |
| Pathway | REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION | 5.75e-05 | 8 | 145 | 3 | M26991 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 6.92e-05 | 68 | 145 | 6 | M27303 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 8.17e-05 | 23 | 145 | 4 | M556 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.16e-04 | 47 | 145 | 5 | MM14925 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.31e-04 | 109 | 145 | 7 | MM15164 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 1.35e-04 | 26 | 145 | 4 | M27483 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 2.61e-04 | 250 | 145 | 10 | M27554 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | NCAM1 COL6A5 PTPRS ACAN MMP12 VWF COL17A1 ITGA8 VCAN NCAN TNXB | 2.73e-04 | 300 | 145 | 11 | M610 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 3.72e-04 | 60 | 145 | 5 | MM15636 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 4.45e-04 | 133 | 145 | 7 | M16476 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 4.68e-04 | 63 | 145 | 5 | M11187 | |
| Pubmed | 4.22e-10 | 8 | 210 | 5 | 9548455 | ||
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 7.88e-10 | 18 | 210 | 6 | 18834073 | |
| Pubmed | 1.29e-09 | 4 | 210 | 4 | 21559424 | ||
| Pubmed | HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. | 1.29e-09 | 4 | 210 | 4 | 21270408 | |
| Pubmed | 3.43e-09 | 11 | 210 | 5 | 7832766 | ||
| Pubmed | SPEG PTPRA PTPRD PTPRF PTPRS ROBO3 CNTN2 CNTN4 LRRC4C CSF1R CNTN3 | 4.82e-09 | 162 | 210 | 11 | 25826454 | |
| Pubmed | 5.86e-09 | 12 | 210 | 5 | 22445338 | ||
| Pubmed | Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells. | 6.43e-09 | 5 | 210 | 4 | 18787130 | |
| Pubmed | 6.43e-09 | 5 | 210 | 4 | 27443384 | ||
| Pubmed | 6.43e-09 | 5 | 210 | 4 | 10777529 | ||
| Pubmed | 6.43e-09 | 5 | 210 | 4 | 37146940 | ||
| Pubmed | 6.43e-09 | 5 | 210 | 4 | 23927735 | ||
| Pubmed | 6.43e-09 | 5 | 210 | 4 | 21087927 | ||
| Pubmed | 6.43e-09 | 5 | 210 | 4 | 20398663 | ||
| Pubmed | 6.43e-09 | 5 | 210 | 4 | 9054430 | ||
| Pubmed | Paired immunoglobulin-like receptor B regulates platelet activation. | 6.43e-09 | 5 | 210 | 4 | 25075127 | |
| Pubmed | Paired immunoglobulin-like receptors and their MHC class I recognition. | 6.43e-09 | 5 | 210 | 4 | 16011512 | |
| Pubmed | Mast cell regulation via paired immunoglobulin-like receptor PIR-B. | 6.43e-09 | 5 | 210 | 4 | 12403357 | |
| Pubmed | 6.43e-09 | 5 | 210 | 4 | 34242819 | ||
| Pubmed | PirB functions as an intrinsic suppressor in hippocampal neural stem cells. | 6.43e-09 | 5 | 210 | 4 | 34120891 | |
| Pubmed | 6.43e-09 | 5 | 210 | 4 | 34437845 | ||
| Pubmed | Inhibitory receptor paired Ig-like receptor B is exploited by Staphylococcus aureus for virulence. | 6.43e-09 | 5 | 210 | 4 | 23152562 | |
| Pubmed | Paternal monoallelic expression of the paired immunoglobulin-like receptors PIR-A and PIR-B. | 6.43e-09 | 5 | 210 | 4 | 10359805 | |
| Pubmed | 6.43e-09 | 5 | 210 | 4 | 9550322 | ||
| Pubmed | Expression of PirB protein in intact and injured optic nerve and retina of mice. | 6.43e-09 | 5 | 210 | 4 | 22102155 | |
| Pubmed | The inhibitory receptor PIR-B negatively regulates neutrophil and macrophage integrin signaling. | 6.43e-09 | 5 | 210 | 4 | 15494528 | |
| Pubmed | PirB regulates a structural substrate for cortical plasticity. | 6.43e-09 | 5 | 210 | 4 | 24302763 | |
| Pubmed | Regulation of plasmacytoid dendritic cell responses by PIR-B. | 6.43e-09 | 5 | 210 | 4 | 22948046 | |
| Pubmed | 6.43e-09 | 5 | 210 | 4 | 27324131 | ||
| Pubmed | The LILR family: modulators of innate and adaptive immune pathways in health and disease. | 6.43e-09 | 5 | 210 | 4 | 15304001 | |
| Pubmed | 6.43e-09 | 5 | 210 | 4 | 20976309 | ||
| Pubmed | 6.43e-09 | 5 | 210 | 4 | 20881122 | ||
| Pubmed | 6.43e-09 | 5 | 210 | 4 | 19684158 | ||
| Pubmed | Paired immunoglobulin-like receptor B is an entry receptor for mammalian orthoreovirus. | 6.43e-09 | 5 | 210 | 4 | 37147336 | |
| Pubmed | Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity. | 6.43e-09 | 5 | 210 | 4 | 33653799 | |
| Pubmed | Structure and flexibility of the extracellular region of the PirB receptor. | 6.43e-09 | 5 | 210 | 4 | 30674550 | |
| Pubmed | 6.43e-09 | 5 | 210 | 4 | 10586026 | ||
| Pubmed | 6.43e-09 | 5 | 210 | 4 | 23258232 | ||
| Pubmed | HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. | 1.92e-08 | 6 | 210 | 4 | 12207326 | |
| Pubmed | 1.92e-08 | 6 | 210 | 4 | 39095838 | ||
| Pubmed | 1.92e-08 | 6 | 210 | 4 | 31727773 | ||
| Pubmed | 1.92e-08 | 6 | 210 | 4 | 21636572 | ||
| Pubmed | 1.92e-08 | 6 | 210 | 4 | 30068593 | ||
| Pubmed | Cell-Autonomous Regulation of Dendritic Spine Density by PirB. | 1.92e-08 | 6 | 210 | 4 | 27752542 | |
| Pubmed | 1.92e-08 | 6 | 210 | 4 | 27402837 | ||
| Pubmed | 1.92e-08 | 6 | 210 | 4 | 28594961 | ||
| Pubmed | The p75 receptor mediates axon growth inhibition through an association with PIR-B. | 1.92e-08 | 6 | 210 | 4 | 21881600 | |
| Pubmed | 1.92e-08 | 6 | 210 | 4 | 15146181 | ||
| Pubmed | Receptor protein tyrosine phosphatases are novel components of a polycystin complex. | 1.92e-08 | 6 | 210 | 4 | 21126580 | |
| Pubmed | 1.92e-08 | 6 | 210 | 4 | 24212998 | ||
| Pubmed | 1.92e-08 | 6 | 210 | 4 | 9824165 | ||
| Pubmed | 1.92e-08 | 6 | 210 | 4 | 38383888 | ||
| Pubmed | PIR-B-deficient mice are susceptible to Salmonella infection. | 1.92e-08 | 6 | 210 | 4 | 18768880 | |
| Pubmed | LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis. | 1.92e-08 | 6 | 210 | 4 | 37481670 | |
| Pubmed | 1.92e-08 | 6 | 210 | 4 | 30787106 | ||
| Pubmed | 1.92e-08 | 6 | 210 | 4 | 9079806 | ||
| Pubmed | 1.92e-08 | 6 | 210 | 4 | 24040397 | ||
| Pubmed | 1.92e-08 | 6 | 210 | 4 | 28664612 | ||
| Pubmed | PirB is a functional receptor for myelin inhibitors of axonal regeneration. | 1.92e-08 | 6 | 210 | 4 | 18988857 | |
| Pubmed | Impaired dendritic cell maturation and increased T(H)2 responses in PIR-B(-/-) mice. | 1.92e-08 | 6 | 210 | 4 | 12021780 | |
| Pubmed | 1.92e-08 | 6 | 210 | 4 | 29482582 | ||
| Pubmed | 1.92e-08 | 6 | 210 | 4 | 25320232 | ||
| Pubmed | Muscleblind-like 1 is required for normal heart valve development in vivo. | 2.19e-08 | 15 | 210 | 5 | 26472242 | |
| Pubmed | A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. | 2.19e-08 | 15 | 210 | 5 | 9144225 | |
| Pubmed | 4.46e-08 | 7 | 210 | 4 | 12376545 | ||
| Pubmed | Paired Ig-like receptors bind to bacteria and shape TLR-mediated cytokine production. | 4.46e-08 | 7 | 210 | 4 | 17371981 | |
| Pubmed | The Nogo-B-PirB axis controls macrophage-mediated vascular remodeling. | 4.46e-08 | 7 | 210 | 4 | 24278366 | |
| Pubmed | 4.46e-08 | 7 | 210 | 4 | 36510132 | ||
| Pubmed | 4.46e-08 | 7 | 210 | 4 | 19687229 | ||
| Pubmed | 4.46e-08 | 7 | 210 | 4 | 21976490 | ||
| Pubmed | Transcriptional activation of the Pirb gene in B cells by PU.1 and Runx3. | 4.46e-08 | 7 | 210 | 4 | 21555536 | |
| Pubmed | A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils. | 4.46e-08 | 7 | 210 | 4 | 18316626 | |
| Pubmed | 4.46e-08 | 7 | 210 | 4 | 17998301 | ||
| Pubmed | Alternative mRNA splicing creates transcripts encoding soluble proteins from most LILR genes. | 4.46e-08 | 7 | 210 | 4 | 19658091 | |
| Pubmed | PirB restricts ocular-dominance plasticity in visual cortex. | 4.46e-08 | 7 | 210 | 4 | 16917027 | |
| Pubmed | 4.46e-08 | 7 | 210 | 4 | 35321392 | ||
| Pubmed | 4.46e-08 | 7 | 210 | 4 | 20844138 | ||
| Pubmed | 4.46e-08 | 7 | 210 | 4 | 27897222 | ||
| Pubmed | NCAM1 PTPRF PTPRS ACAN MERTK CNTN2 CNTN4 CSF1R CNTN3 PRG4 TNXB PROC | 6.28e-08 | 257 | 210 | 12 | 16335952 | |
| Pubmed | NCAM1 AEBP1 PKD1 FGFR3 COL17A1 VWA1 VCAN NCAN DLL3 PRG4 TNXB | 7.05e-08 | 210 | 210 | 11 | 16537572 | |
| Pubmed | LDLRAP1 HLA-B MBD1 STAB1 PTPRA WIZ PTPRD TPP1 PKD1 MERTK CAP2 CNTN4 VLDLR DMXL2 EXOSC9 VWF MAGED1 MYRIP GRIN2B USP8 NISCH MACF1 PRKDC ZMYM5 SMAD2 SEZ6L | 7.81e-08 | 1285 | 210 | 26 | 35914814 | |
| Pubmed | 8.87e-08 | 8 | 210 | 4 | 18209065 | ||
| Pubmed | NogoR1 and PirB signaling stimulates neural stem cell survival and proliferation. | 8.87e-08 | 8 | 210 | 4 | 24449409 | |
| Pubmed | Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development. | 8.87e-08 | 8 | 210 | 4 | 22660330 | |
| Pubmed | 8.87e-08 | 8 | 210 | 4 | 21376641 | ||
| Pubmed | VCAM1 confers innate immune tolerance on haematopoietic and leukaemic stem cells. | 8.87e-08 | 8 | 210 | 4 | 35210567 | |
| Pubmed | 8.87e-08 | 8 | 210 | 4 | 19255189 | ||
| Pubmed | Genomic structures and chromosomal location of p91, a novel murine regulatory receptor family. | 8.87e-08 | 8 | 210 | 4 | 9538215 | |
| Pubmed | 8.87e-08 | 8 | 210 | 4 | 28637841 | ||
| Pubmed | Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation. | 1.59e-07 | 9 | 210 | 4 | 17420263 | |
| Pubmed | 2.17e-07 | 3 | 210 | 3 | 20139422 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 2.17e-07 | 3 | 210 | 3 | 33656439 | |
| Pubmed | 2.17e-07 | 3 | 210 | 3 | 9784606 | ||
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 2.17e-07 | 3 | 210 | 3 | 31985401 | |
| Pubmed | Differential activation of recombinant human acetyl-CoA carboxylases 1 and 2 by citrate. | 2.17e-07 | 3 | 210 | 3 | 18455495 | |
| Pubmed | 2.17e-07 | 3 | 210 | 3 | 14662864 | ||
| Pubmed | Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development. | 2.64e-07 | 10 | 210 | 4 | 18802077 | |
| Pubmed | PIRs mediate innate myeloid cell memory to nonself MHC molecules. | 2.64e-07 | 10 | 210 | 4 | 32381589 | |
| Pubmed | 4.12e-07 | 11 | 210 | 4 | 25624497 | ||
| Pubmed | 4.12e-07 | 11 | 210 | 4 | 24738827 | ||
| Interaction | LILRA3 interactions | 2.94e-06 | 11 | 200 | 4 | int:LILRA3 | |
| Cytoband | 19q13.4 | 3.31e-09 | 79 | 210 | 8 | 19q13.4 | |
| GeneFamily | Fibronectin type III domain containing | MYLK MYOM1 NCAM1 PTPRD PTPRF PTPRH PTPRS PTPRQ FNDC9 ROBO3 MERTK CNTN2 IL27RA MPL CNTN4 VWA1 CNTN3 TNXB EPHA5 | 7.71e-17 | 160 | 151 | 19 | 555 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | MYLK MYOM1 SPEG NCAM1 HMCN2 PTPRD PTPRF PTPRS FGFR3 ROBO3 MERTK CNTN2 CNTN4 MXRA5 NTRK3 LRRC4C CNTN3 | 2.58e-14 | 161 | 151 | 17 | 593 |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 1.50e-08 | 21 | 151 | 6 | 813 | |
| GeneFamily | CD molecules|Mucins | 1.50e-08 | 21 | 151 | 6 | 648 | |
| GeneFamily | CD molecules|Activating leukocyte immunoglobulin like receptors | 6.92e-08 | 6 | 151 | 4 | 1181 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.59e-07 | 57 | 151 | 7 | 1179 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.27e-06 | 4 | 151 | 3 | 574 | |
| GeneFamily | Immunoglobulin like domain containing | 5.18e-06 | 193 | 151 | 10 | 594 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | LILRB2 ENPP3 NCAM1 LILRB1 FGFR3 MPL LILRA1 LILRA3 LILRA2 CSF1R IL21R TNFRSF13C LILRA4 CD276 | 5.71e-06 | 394 | 151 | 14 | 471 |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 3.38e-04 | 40 | 151 | 4 | 321 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.72e-04 | 41 | 151 | 4 | 1298 | |
| GeneFamily | CD molecules|Inhibitory leukocyte immunoglobulin like receptors | 6.82e-04 | 5 | 151 | 2 | 1182 | |
| GeneFamily | Cyclin dependent kinases | 1.29e-03 | 26 | 151 | 3 | 496 | |
| GeneFamily | Ankyrin repeat domain containing | 4.27e-03 | 242 | 151 | 7 | 403 | |
| GeneFamily | Zinc fingers CXXC-type | 4.33e-03 | 12 | 151 | 2 | 136 | |
| Coexpression | GSE6259_33D1_POS_DC_VS_CD4_TCELL_DN | ABCA1 ZFYVE9 LPCAT2 TPP1 GBGT1 MERTK DMXL2 USP8 PLXNA4 MACF1 | 1.54e-06 | 176 | 208 | 10 | M6757 |
| Coexpression | PILON_KLF1_TARGETS_UP | PIGN MASP1 ABCA1 MYLK HLA-B DAB2 PTPRD PTPRF AEBP1 PLA1A ABCC8 PKD2 CAP2 VWF MAGED1 CRX USP8 | 1.69e-06 | 541 | 208 | 17 | MM1061 |
| Coexpression | NABA_CORE_MATRISOME | COL6A5 HMCN2 AEBP1 ACAN MXRA5 VWF COL17A1 VWA1 VCAN NCAN PRG4 TNXB | 2.24e-06 | 275 | 208 | 12 | M5884 |
| Coexpression | DESCARTES_FETAL_INTESTINE_MYELOID_CELLS | ABCA1 LILRB2 LILRB1 STAB1 MERTK LILRA1 LILRA2 WDFY4 CSF1R TNFRSF13C RUFY4 | 2.48e-06 | 230 | 208 | 11 | M40210 |
| Coexpression | PILON_KLF1_TARGETS_UP | PIGN MASP1 ABCA1 MYLK DAB2 PTPRD PTPRF AEBP1 PLA1A ABCC8 PKD2 CAP2 VWF MAGED1 CRX USP8 | 2.96e-06 | 503 | 208 | 16 | M2226 |
| Coexpression | VILIMAS_NOTCH1_TARGETS_DN | 6.92e-06 | 34 | 208 | 5 | MM791 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_D_DN | 1.02e-05 | 94 | 208 | 7 | MM787 | |
| Coexpression | NABA_CORE_MATRISOME | COL6A5 HMCN2 AEBP1 ACAN VWF COL17A1 VWA1 VCAN NCAN PRG4 TNXB | 1.14e-05 | 270 | 208 | 11 | MM17057 |
| Coexpression | SOUCEK_MYC_TARGETS | 1.36e-05 | 19 | 208 | 4 | MM1252 | |
| Coexpression | NABA_MATRISOME | MASP1 COL6A5 HMCN2 AEBP1 ACAN MMP12 MUC20 MXRA5 VWF COL17A1 MUC15 MUC19 MUC16 MUC5B VWA1 OVGP1 ADAMTS7 VCAN NCAN PLXNA4 PRG4 TNXB | 2.44e-05 | 1026 | 208 | 22 | M5889 |
| Coexpression | ROVERSI_GLIOMA_LOH_REGIONS | 2.83e-05 | 45 | 208 | 5 | M6712 | |
| Coexpression | GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP | 2.97e-05 | 197 | 208 | 9 | M3307 | |
| Coexpression | GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP | 3.21e-05 | 199 | 208 | 9 | M6839 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_8_PRECICTIVE_ICB_RESPONSE | 3.34e-05 | 200 | 208 | 9 | MM17082 | |
| Coexpression | GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_DN | 3.34e-05 | 200 | 208 | 9 | M3091 | |
| Coexpression | GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_DN | 3.34e-05 | 200 | 208 | 9 | M3088 | |
| Coexpression | DESCARTES_FETAL_HEART_SATB2_LRRC7_POSITIVE_CELLS | 3.80e-05 | 115 | 208 | 7 | M40201 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING | 4.75e-05 | 50 | 208 | 5 | MM3805 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 5.67e-05 | 166 | 208 | 8 | M39026 | |
| Coexpression | NABA_MATRISOME | MASP1 COL6A5 HMCN2 AEBP1 ACAN MMP12 MUC20 VWF COL17A1 MUC15 MUC19 MUC16 MUC5B VWA1 OVGP1 ADAMTS7 VCAN NCAN PLXNA4 PRG4 TNXB | 5.70e-05 | 1008 | 208 | 21 | MM17056 |
| Coexpression | MIKKELSEN_MEF_LCP_WITH_H3K4ME3 | 7.52e-05 | 128 | 208 | 7 | M1966 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP | 8.55e-05 | 176 | 208 | 8 | MM1048 | |
| Coexpression | HEVNER_INTERMEDIATE_ZONE_AND_UP_POSTMITOTIC_PROJECTION_NEURONS | 8.98e-05 | 57 | 208 | 5 | MM415 | |
| Coexpression | VALK_AML_CLUSTER_5 | 1.16e-04 | 32 | 208 | 4 | M14437 | |
| Coexpression | LIAN_LIPA_TARGETS_6M | 1.26e-04 | 97 | 208 | 6 | MM1016 | |
| Coexpression | MIKKELSEN_MEF_LCP_WITH_H3K4ME3 | 1.44e-04 | 142 | 208 | 7 | MM840 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | CDR2 ABCA1 HEPH STAB1 PTPRD PKD2 IL27RA VWF TNS2 MACF1 TNXB EPHA5 | 1.51e-04 | 422 | 208 | 12 | M7396 |
| Coexpression | DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS | 1.53e-04 | 244 | 208 | 9 | M40312 | |
| Coexpression | GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_UP | 1.56e-04 | 192 | 208 | 8 | M9509 | |
| Coexpression | NABA_PROTEOGLYCANS | 1.66e-04 | 35 | 208 | 4 | M5882 | |
| Coexpression | GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_DN | 1.68e-04 | 194 | 208 | 8 | M6134 | |
| Coexpression | NABA_PROTEOGLYCANS | 1.86e-04 | 36 | 208 | 4 | MM17061 | |
| Coexpression | GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP | 1.86e-04 | 197 | 208 | 8 | M8672 | |
| Coexpression | GSE3039_NKT_CELL_VS_B1_BCELL_UP | 1.99e-04 | 199 | 208 | 8 | M6432 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_LUNG_DN | 1.99e-04 | 199 | 208 | 8 | M4350 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN | 2.06e-04 | 200 | 208 | 8 | M7518 | |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_DN | 2.06e-04 | 200 | 208 | 8 | M6258 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN | 2.06e-04 | 200 | 208 | 8 | M4496 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | MASP1 CSMD2 FASN FGFR3 ROBO3 FOXJ1 FAT3 NTRK3 LRRC4C IRX1 NCAN SEZ6L | 2.17e-04 | 439 | 208 | 12 | M39054 |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | CDR2 ABCA1 HEPH STAB1 PTPRD PKD2 IL27RA VWF TNS2 MACF1 TNXB EPHA5 | 2.41e-04 | 444 | 208 | 12 | MM1051 |
| Coexpression | DESCARTES_FETAL_CEREBRUM_MICROGLIA | HFE LILRB2 APOBR LILRB1 LPCAT2 GBGT1 MERTK GPR132 LILRA1 LILRA2 WDFY4 CSF1R LILRA4 | 2.64e-04 | 516 | 208 | 13 | M40168 |
| Coexpression | NABA_ECM_AFFILIATED | 2.78e-04 | 158 | 208 | 7 | MM17063 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C11_PANETH_LIKE_CELL | ABCA1 LILRB2 DAB2 LILRB1 STAB1 TPP1 MERTK GPR132 WDFY4 CSF1R | 2.82e-04 | 324 | 208 | 10 | M39160 |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE | 2.96e-04 | 211 | 208 | 8 | MM17081 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HOMTN | KCNH8 KIF26A ABCC8 FNDC9 CNTN2 CAP2 CNTN4 STXBP5 THSD7B PLXNA4 DMTN | 2.98e-04 | 389 | 208 | 11 | M39073 |
| Coexpression | DESCARTES_ORGANOGENESIS_GRANULE_NEURONS | 3.10e-04 | 41 | 208 | 4 | MM3647 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN | 3.23e-04 | 162 | 208 | 7 | M7002 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | MYLK PTPRD FGFR3 ARAP1 VLDLR MAGED1 PCDHGA9 FAT3 ITGA8 NISCH VCAN MACF1 | 1.39e-10 | 193 | 209 | 12 | 8d05805295c5d3aa93aeb38be5fbefa81e1be1f0 |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | MYLK PTPRD FGFR3 ARAP1 VLDLR MAGED1 PCDHGA9 FAT3 ITGA8 NISCH VCAN MACF1 | 1.39e-10 | 193 | 209 | 12 | 1b2cc627b2aa002b442358bd1188d470e67ce7d9 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CTTNBP2 COL6A5 PTPRQ CNTN4 FAT3 MUC19 ATP13A5 MUC5B GRIN2B CNTN3 EPHA5 | 2.83e-10 | 160 | 209 | 11 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CTTNBP2 COL6A5 PTPRQ CNTN4 FAT3 MUC19 ATP13A5 MUC5B GRIN2B CNTN3 EPHA5 | 2.83e-10 | 160 | 209 | 11 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | MYLK NCAM1 PTPRD ARAP1 VLDLR MAGED1 GPX7 ITGA8 VCAN MACF1 EPHA5 | 2.19e-09 | 194 | 209 | 11 | f2f7b9aad7588c8020a4850ff9333e1db8eafac7 |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | MYLK PTPRD FGFR3 ARAP1 VLDLR MAGED1 PCDHGA9 ITGA8 NISCH VCAN MACF1 | 2.31e-09 | 195 | 209 | 11 | b616ee6f1d878935d293c8e0a8bbc5b4385301f0 |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | MYLK PTPRD FGFR3 ARAP1 VLDLR MAGED1 PCDHGA9 ITGA8 NISCH VCAN MACF1 | 2.31e-09 | 195 | 209 | 11 | 2f9a274b26fc528a85f50933ec2f4db1dc9da0ca |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | CTTNBP2 LILRB2 DAB2 STAB1 LPCAT2 MERTK MMP12 DMXL2 CSF1R RUFY4 CD276 | 2.43e-09 | 196 | 209 | 11 | 075e5746fa5cb121115a1d51b823c0fbf8d54305 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | MYLK COL6A5 PTPRD AEBP1 PTPRS FAT3 ITGA8 KANK4 MACF1 PRG4 TNXB | 2.57e-09 | 197 | 209 | 11 | 13896ec65ccda0b928c91d41112dc01b480036b7 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | ABCA1 CTTNBP2 LILRB2 DAB2 STAB1 MERTK MMP12 DMXL2 PKD2L1 IL18BP CSF1R | 2.57e-09 | 197 | 209 | 11 | e698a0bbb20bd4868ff4348f2ac9f609942b55fa |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | ABCA1 CTTNBP2 LILRB2 DAB2 APOBR LILRB1 STAB1 MERTK DMXL2 WDFY4 CSF1R | 2.86e-09 | 199 | 209 | 11 | f34c15df58fbdc6c90e30800e26fabbf828ad10b |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.39e-09 | 170 | 209 | 10 | 9ac1ef57f14418a5dd2aa16861c3df698c28f5ed | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | MYLK COL6A5 HEPH PTPRD PTPRS PTPRQ MXRA5 ITGA8 KANK4 IBA57-DT | 1.23e-08 | 177 | 209 | 10 | 8220cc2fc0ee8764a67a3be51d75248be2453040 |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | MYLK COL6A5 HEPH PTPRD PTPRS PTPRQ MXRA5 ITGA8 KANK4 IBA57-DT | 1.23e-08 | 177 | 209 | 10 | 7617270f49cd6b7ba66db72d20560cee985012b2 |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | ABCA1 CTTNBP2 LILRB2 DAB2 STAB1 LPCAT2 MERTK MMP12 DMXL2 CSF1R | 1.45e-08 | 180 | 209 | 10 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | MASP1 CTTNBP2 MYLK NCAM1 AEBP1 CAP2 PCDHA10 KIAA1755 CNTN3 TNXB | 1.53e-08 | 181 | 209 | 10 | b116c68393d8836bac080f81a8fcbeb52e0403e7 |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | CTTNBP2 CDK15 LILRB2 ENPP3 DAB2 STAB1 LPCAT2 DMXL2 CSF1R VCAN | 2.30e-08 | 189 | 209 | 10 | 2aebea7a6c2f83112d7c504b742f2c04b92e459a |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.10e-08 | 195 | 209 | 10 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | CSMD2 HMCN2 PTPRD ABCC8 SCN10A FAT3 MUC19 MUC16 THSD7B CNTN3 | 3.10e-08 | 195 | 209 | 10 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.10e-08 | 195 | 209 | 10 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.10e-08 | 195 | 209 | 10 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | CSMD2 HMCN2 PTPRD ABCC8 SCN10A FAT3 MUC19 MUC16 THSD7B CNTN3 | 3.10e-08 | 195 | 209 | 10 | d3755929ebbbf5e3afde44281e9056ddb614a291 |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.10e-08 | 195 | 209 | 10 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-08 | 196 | 209 | 10 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-08 | 196 | 209 | 10 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.25e-08 | 196 | 209 | 10 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.25e-08 | 196 | 209 | 10 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Non-resident_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.41e-08 | 197 | 209 | 10 | 774a5053f43ac7d614c127ae7363d32a3a194f63 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | LILRB2 LILRB1 STAB1 MERTK ARAP1 LILRA1 WDFY4 CSF1R IL21R RUFY4 | 3.58e-08 | 198 | 209 | 10 | 0b928a829844f49f4d47e88908af192cb919011f |
| ToppCell | mLN-Macrophage-Macrophage|mLN / Region, Cell class and subclass | LILRB2 DAB2 STAB1 ABCC8 MERTK MMP12 LILRA1 DMXL2 PKD2L1 CSF1R | 3.75e-08 | 199 | 209 | 10 | 6bbec8450afb30347b07da28401a698fc51a3c53 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.75e-08 | 199 | 209 | 10 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.75e-08 | 199 | 209 | 10 | 2cec0e370ee9bb3c88a7acb5519e9ea8ddb399bc | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CCL|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | LILRB2 APOBR LILRB1 STAB1 LILRA1 LILRA2 WDFY4 CSF1R RUFY4 LILRA4 | 3.75e-08 | 199 | 209 | 10 | c72279fa3ca2ebc42a1446507673df154b8033c7 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ABCA1 COL6A5 FASN PTPRD CNTN4 MXRA5 VCAN PLXNA4 KIAA1755 TNXB | 3.75e-08 | 199 | 209 | 10 | 8b86c69aaf60feff53aa782559cfece7342a23de |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.75e-08 | 199 | 209 | 10 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | ABCA1 LILRB2 APOBR LILRB1 STAB1 MERTK DMXL2 WDFY4 CSF1R TNFRSF13C | 3.75e-08 | 199 | 209 | 10 | 5ceeed92f831d068ff4bb3994f420002338330e7 |
| ToppCell | mLN-(6)_Macrophage-(60)_Macrophage|mLN / shred on region, Cell_type, and subtype | LILRB2 DAB2 STAB1 ABCC8 MERTK MMP12 LILRA1 DMXL2 PKD2L1 CSF1R | 3.75e-08 | 199 | 209 | 10 | 1ea28b832c6173b1b58da432aaf21e6cd291561e |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.75e-08 | 199 | 209 | 10 | 9e87b64e16d595701c3beb07aa835afe3330bd10 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.75e-08 | 199 | 209 | 10 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.93e-08 | 200 | 209 | 10 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.93e-08 | 200 | 209 | 10 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.93e-08 | 200 | 209 | 10 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.93e-08 | 200 | 209 | 10 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | LILRB2 LILRB1 STAB1 LILRA1 DMXL2 LILRA2 WDFY4 CSF1R VCAN SEZ6L | 3.93e-08 | 200 | 209 | 10 | 8872d5fa101d413fb43b4231d476878678543035 |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | LILRB2 LILRB1 LPCAT2 LILRA1 DMXL2 LILRA2 CSF1R VCAN SEZ6L RUFY4 | 3.93e-08 | 200 | 209 | 10 | fc061de0db2e8b5ca47f5e2a1e861018e7f1b582 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.93e-08 | 200 | 209 | 10 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.75e-08 | 162 | 209 | 9 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 8.61e-08 | 164 | 209 | 9 | 519ab4fe885dfe4c50846f346a062acc2cb44299 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.55e-08 | 166 | 209 | 9 | 83d0c26ccee605df6b04bbca31661bf4ff4f22ba | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-interstitial_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-07 | 170 | 209 | 9 | f664c7559e383b37845c123e41a3be316d869ba0 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.17e-07 | 170 | 209 | 9 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-07 | 170 | 209 | 9 | 0272eb1487c2545d4aa06f5d1cd77f823e1441e9 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-07 | 173 | 209 | 9 | 26bba58f9fb215d1d155504906cd77e8774f6936 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-07 | 173 | 209 | 9 | 69b404e92aad3e6dff67e75466f073f20a71f13f | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.09e-07 | 182 | 209 | 9 | ea39b1b5db185b0cb11dfa2e01f3f972effbd770 | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic|GI_large-bowel / Manually curated celltypes from each tissue | 2.75e-07 | 188 | 209 | 9 | d0045fdda757d191dabc7853f6a6e99c0e97d93d | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.75e-07 | 188 | 209 | 9 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes|GI_large-bowel / Manually curated celltypes from each tissue | 2.75e-07 | 188 | 209 | 9 | 0bcf04aa47738f43c1a87dae5dc487738ee86f8c | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-07 | 188 | 209 | 9 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.01e-07 | 190 | 209 | 9 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Non-resident_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.01e-07 | 190 | 209 | 9 | 4fe9654a9b449ef49ca10b973ac4378dab34cb53 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CTTNBP2 KCNH8 CSMD2 PTPRD MERTK LRRC4C TADA1 TMEM132E PLXNA4 | 3.01e-07 | 190 | 209 | 9 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-07 | 191 | 209 | 9 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-07 | 191 | 209 | 9 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | Adult-Immune-monocyte-D175|Adult / Lineage, Cell type, age group and donor | 3.15e-07 | 191 | 209 | 9 | cbebb4d9550fdcd606cb3685ac9546c6b73fd422 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.15e-07 | 191 | 209 | 9 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | NS-critical-d_0-4|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.15e-07 | 191 | 209 | 9 | 769942a6a31c13c583dc38e8a762df2f5c06c2fb | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.29e-07 | 192 | 209 | 9 | 0afb9dbe468e0be442c326e11c5fc0f699b32f23 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.44e-07 | 193 | 209 | 9 | b637e1c47a98009e7d19a6daac78f888fd12748f | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.44e-07 | 193 | 209 | 9 | 826457e2aafdb61ead8a0a44d8cf9088d310684b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.59e-07 | 194 | 209 | 9 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 3.75e-07 | 195 | 209 | 9 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | NS-critical-d_07-13-Myeloid-Non-resident_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.75e-07 | 195 | 209 | 9 | ee8743d39996bb756f50db32748e8a902d3294b8 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-07 | 195 | 209 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.75e-07 | 195 | 209 | 9 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.75e-07 | 195 | 209 | 9 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | HLA-B LILRB2 APOBR LILRB1 STAB1 LILRA1 WDFY4 CSF1R TNFRSF13C | 3.75e-07 | 195 | 209 | 9 | 97a9410f47beca02346902d078288a75bfe6e56b |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-07 | 195 | 209 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 3.91e-07 | 196 | 209 | 9 | 256c557fa11414c9d2cbb1fcff33f482ee1c78ac | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Neutrophils|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.91e-07 | 196 | 209 | 9 | 376c5a459a484205fbb0db34936e4a6146d1f622 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.91e-07 | 196 | 209 | 9 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.91e-07 | 196 | 209 | 9 | 028a06ed92f1c058dcbeacd335625bf529e87a7b | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.91e-07 | 196 | 209 | 9 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.91e-07 | 196 | 209 | 9 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.91e-07 | 196 | 209 | 9 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.08e-07 | 197 | 209 | 9 | 48a8169a4d33c6a68d66bcd936861c75cb4b60ef | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 4.08e-07 | 197 | 209 | 9 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| ToppCell | 390C-Myeloid-Monocyte-CD16+_Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.08e-07 | 197 | 209 | 9 | 01f5f5c34e904cc0146e978cc05ed1cd86a41533 | |
| ToppCell | Dendritic_cell|World / shred by cell class for turbinate | 4.08e-07 | 197 | 209 | 9 | ab2213e3742f92798922ea318d76328b6ca18b13 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.08e-07 | 197 | 209 | 9 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-07 | 197 | 209 | 9 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | (6)_Macrophage|World / shred on Cell_type and subtype | 4.08e-07 | 197 | 209 | 9 | 010b275d4da4a896175ad7fbaa96d1dc11a0b744 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 4.08e-07 | 197 | 209 | 9 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.08e-07 | 197 | 209 | 9 | 8b9a88fb671d5c2b25d291c851e2b8a478f2610c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.08e-07 | 197 | 209 | 9 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.26e-07 | 198 | 209 | 9 | af682919a874d60f579e854c274dc47063015ea9 | |
| ToppCell | Mild-Myeloid-Macrophages-FCN1_high|Mild / Condition, Lineage, Cell class and cell subclass | 4.26e-07 | 198 | 209 | 9 | 17aab4dc3b2cd6eb7dda77dd51bdc20490fcfe19 | |
| ToppCell | distal-mesenchymal-Fibromyocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.26e-07 | 198 | 209 | 9 | 9d1d95e7703cfc70a8ad427e400c340dbd205db8 | |
| ToppCell | NS-moderate-d_16-33-Myeloid-Non-resident_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.26e-07 | 198 | 209 | 9 | 11a7a553de6786c1e8288251ba0d5c898505c158 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.26e-07 | 198 | 209 | 9 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| Computational | Genes in the cancer module 27. | HFE HLA-B LILRB2 CHRNB1 PTPRF PTPRH PTPRS FGFR3 MERTK IL27RA MPL LILRA1 LILRA3 LILRA2 GRM2 | 1.51e-05 | 355 | 125 | 15 | MODULE_27 |
| Drug | Prednisolone [50-24-8]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.22e-06 | 199 | 207 | 11 | 5526_UP | |
| Drug | Gdrgdsp | 7.06e-06 | 109 | 207 | 8 | CID000115346 | |
| Drug | IL-T | 1.17e-05 | 56 | 207 | 6 | CID000150551 | |
| Drug | Flutamide [13311-84-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 1.20e-05 | 194 | 207 | 10 | 3885_UP | |
| Drug | Orlistat; Up 200; 10uM; MCF7; HT_HG-U133A | 1.25e-05 | 195 | 207 | 10 | 6415_UP | |
| Drug | Piroxicam [36322-90-4]; Up 200; 12uM; MCF7; HT_HG-U133A | MYLK LILRB2 STAB1 HROB C22orf31 TPP1 ABCC8 FGFR3 MUC5B CSF1R | 1.37e-05 | 197 | 207 | 10 | 2252_UP |
| Drug | Methylatropine nitrate [52-88-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.43e-05 | 198 | 207 | 10 | 6495_UP | |
| Drug | Oxyphenbutazone [129-20-4]; Up 200; 12.4uM; HL60; HT_HG-U133A | 1.43e-05 | 198 | 207 | 10 | 6160_UP | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 1 measurement | 2.69e-06 | 15 | 201 | 4 | EFO_0008208 | |
| Disease | muscular disease (implicated_via_orthology) | 3.08e-06 | 5 | 201 | 3 | DOID:0080000 (implicated_via_orthology) | |
| Disease | apolipoprotein B measurement | HFE LDLRAP1 ACACB HLA-B PEX6 ATXN2 SNX8 OSGIN1 VLDLR PKD2L1 USP8 GPR61 NISCH NCAN KANK4 DMTN | 1.39e-05 | 663 | 201 | 16 | EFO_0004615 |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.07e-05 | 53 | 201 | 5 | C4707243 | |
| Disease | azoospermia (implicated_via_orthology) | 3.24e-05 | 27 | 201 | 4 | DOID:14227 (implicated_via_orthology) | |
| Disease | heel bone mineral density, urate measurement | 3.75e-05 | 182 | 201 | 8 | EFO_0004531, EFO_0009270 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 2 measurement | 4.94e-05 | 11 | 201 | 3 | EFO_0008209 | |
| Disease | intracranial aneurysm (is_implicated_in) | 6.55e-05 | 12 | 201 | 3 | DOID:10941 (is_implicated_in) | |
| Disease | risk-taking behaviour | KIF26A NCAM1 ERLEC1 PTPRF CC2D2A TET3 CNTN2 NOA1 NTRK3 GRIN2B LRRC4C THSD7B TNXB PROC EPHA5 CD276 | 7.57e-05 | 764 | 201 | 16 | EFO_0008579 |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 8.47e-05 | 13 | 201 | 3 | C1846647 | |
| Disease | Bagassosis | 1.07e-04 | 14 | 201 | 3 | C0004681 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 1.07e-04 | 14 | 201 | 3 | DOID:898 (implicated_via_orthology) | |
| Disease | Pneumoconiosis | 1.07e-04 | 14 | 201 | 3 | C0032273 | |
| Disease | basophil count | HFE HLA-B COL6A5 ATXN2 CA5A CNTN4 PKD2L1 TNFRSF13C PKN2 PRKDC TNXB RUFY4 | 1.29e-04 | 483 | 201 | 12 | EFO_0005090 |
| Disease | polycystic kidney disease 2 (implicated_via_orthology) | 1.38e-04 | 3 | 201 | 2 | DOID:0110859 (implicated_via_orthology) | |
| Disease | nt-3 growth factor receptor measurement | 1.38e-04 | 3 | 201 | 2 | EFO_0020613 | |
| Disease | Autosomal dominant polycystic kidney disease | 1.38e-04 | 3 | 201 | 2 | cv:C0085413 | |
| Disease | aspartate aminotransferase measurement | HFE ABCA1 DAB2 HMCN2 PTPRD ATXN2 SNX8 MERTK CNTN2 NYAP2 MUC19 PKD2L1 THSD7B USP8 CSF1R PKN2 CD276 | 1.65e-04 | 904 | 201 | 17 | EFO_0004736 |
| Disease | mean arterial pressure | HFE NCAM1 PTPRD ATXN2 MERTK NYAP2 STXBP5 PKD2L1 TNS2 THSD7B USP8 SEZ6 | 1.75e-04 | 499 | 201 | 12 | EFO_0006340 |
| Disease | HbA1c measurement | HFE ACACB HROB PTPRH AEBP1 ATXN2 ABCC8 ARAP1 NYAP2 GPX7 PKD2L1 ADAMTS7 MACF1 SEZ6 | 2.36e-04 | 675 | 201 | 14 | EFO_0004541 |
| Disease | autosomal dominant polycystic kidney disease (is_implicated_in) | 2.75e-04 | 4 | 201 | 2 | DOID:898 (is_implicated_in) | |
| Disease | osteonecrosis (is_marker_for) | 2.75e-04 | 4 | 201 | 2 | DOID:10159 (is_marker_for) | |
| Disease | factor VIII measurement, Ischemic stroke | 2.78e-04 | 19 | 201 | 3 | EFO_0004630, HP_0002140 | |
| Disease | Autism Spectrum Disorders | 2.94e-04 | 85 | 201 | 5 | C1510586 | |
| Disease | cortical surface area measurement | DDAH2 CTTNBP2 HLA-B ENPP3 NCAM1 PTPRF ATXN2 GLIS2 PKD1 FGFR3 CCDC33 NYAP2 FAT3 KIAA1614 ADAMTS7 VCAN KIAA1755 MACF1 PKN2 TNXB PROC | 3.64e-04 | 1345 | 201 | 21 | EFO_0010736 |
| Disease | smoking status measurement | CTTNBP2 KIF26A NCAM1 ADAR STAB1 PTPRD PTPRF ATXN2 CC2D2A TET3 CNTN4 NYAP2 FAT3 LRRC4C THSD7B PLXNA4 CNTN3 CD276 SEZ6 | 3.91e-04 | 1160 | 201 | 19 | EFO_0006527 |
| Disease | disease recurrence, colon carcinoma | 4.07e-04 | 51 | 201 | 4 | EFO_0004952, EFO_1001950 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | CTTNBP2 KIF26A NCAM1 PTPRF ATXN2 TET3 TDRKH NYAP2 NTRK3 LRRC4C THSD7B PLXNA4 CNTN3 PRKDC CD276 | 4.19e-04 | 801 | 201 | 15 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | ubiquitin carboxyl-terminal hydrolase 25 measurement | 4.36e-04 | 22 | 201 | 3 | EFO_0021881 | |
| Disease | Autistic Disorder | 4.46e-04 | 261 | 201 | 8 | C0004352 | |
| Disease | human papilloma virus infection, oropharynx cancer | 4.71e-04 | 53 | 201 | 4 | EFO_0001668, EFO_1001931 | |
| Disease | Adenocarcinoma of lung (disorder) | 5.52e-04 | 206 | 201 | 7 | C0152013 | |
| Disease | ovarian cancer (is_implicated_in) | 5.82e-04 | 56 | 201 | 4 | DOID:2394 (is_implicated_in) | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 6.43e-04 | 276 | 201 | 8 | EFO_0004612, EFO_0020943 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 6.53e-04 | 153 | 201 | 6 | EFO_0004611, EFO_0020946 | |
| Disease | essential thrombocythemia (is_implicated_in) | 6.80e-04 | 6 | 201 | 2 | DOID:2224 (is_implicated_in) | |
| Disease | crescentic glomerulonephritis (implicated_via_orthology) | 6.80e-04 | 6 | 201 | 2 | DOID:13139 (implicated_via_orthology) | |
| Disease | Polycystic Kidney Diseases | 6.80e-04 | 6 | 201 | 2 | C0022680 | |
| Disease | Human papillomavirus infectious disease (is_implicated_in) | 6.80e-04 | 6 | 201 | 2 | DOID:11166 (is_implicated_in) | |
| Disease | beta-hydroxybutyric acid measurement | 6.80e-04 | 6 | 201 | 2 | EFO_0010465 | |
| Disease | achondroplasia (implicated_via_orthology) | 6.80e-04 | 6 | 201 | 2 | DOID:4480 (implicated_via_orthology) | |
| Disease | waist-hip ratio | ABCA1 DAB2 NCAM1 STAB1 PTPRD ATXN2 PTPRS ABCC8 PKD1 MINDY4 CNTN2 SEC16B DMXL2 NYAP2 GRIN2B IRX1 NISCH MOGAT3 SMAD2 | 7.62e-04 | 1226 | 201 | 19 | EFO_0004343 |
| Disease | phosphatidylcholine measurement | 7.74e-04 | 284 | 201 | 8 | EFO_0010226 | |
| Disease | factor VIII measurement, von Willebrand factor measurement | 8.07e-04 | 27 | 201 | 3 | EFO_0004629, EFO_0004630 | |
| Disease | fatty acid measurement | ABCA1 ACACB HLA-B PTPRD NYAP2 PKD2L1 GPR61 NCAN PLXNA4 MACF1 | 8.67e-04 | 436 | 201 | 10 | EFO_0005110 |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 9.03e-04 | 224 | 201 | 7 | EFO_0004530, EFO_0008317 | |
| Disease | level of oxylipin in blood plasma | 9.48e-04 | 7 | 201 | 2 | OBA_2050338 | |
| Disease | left ventricular stroke volume measurement | 9.48e-04 | 7 | 201 | 2 | EFO_0010555 | |
| Disease | Polycystic kidney disease, type 2 | 9.48e-04 | 7 | 201 | 2 | C2751306 | |
| Disease | rheumatoid arthritis, COVID-19 | 9.65e-04 | 64 | 201 | 4 | EFO_0000685, MONDO_0100096 | |
| Disease | squamous cell lung carcinoma | 9.67e-04 | 165 | 201 | 6 | EFO_0000708 | |
| Disease | phospholipids:total lipids ratio | 9.76e-04 | 227 | 201 | 7 | EFO_0020946 | |
| Disease | susceptibility to cold sores measurement | 1.02e-03 | 65 | 201 | 4 | EFO_0008402 | |
| Disease | sclerosing cholangitis | 1.08e-03 | 66 | 201 | 4 | EFO_0004268 | |
| Disease | Ischemic stroke, von Willebrand factor measurement | 1.10e-03 | 30 | 201 | 3 | EFO_0004629, HP_0002140 | |
| Disease | body mass index, coronary artery disease | 1.26e-03 | 8 | 201 | 2 | EFO_0001645, EFO_0004340 | |
| Disease | myelofibrosis (is_implicated_in) | 1.26e-03 | 8 | 201 | 2 | DOID:4971 (is_implicated_in) | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 1.26e-03 | 8 | 201 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | waist circumference, sexual dimorphism | 1.26e-03 | 8 | 201 | 2 | EFO_0004342, EFO_0005951 | |
| Disease | Polycystic Kidney, Type 1 Autosomal Dominant Disease | 1.26e-03 | 8 | 201 | 2 | C0887850 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 1.31e-03 | 239 | 201 | 7 | EFO_0010934 | |
| Disease | Squamous cell carcinoma of lung | 1.34e-03 | 32 | 201 | 3 | C0149782 | |
| Disease | upper aerodigestive tract neoplasm | 1.55e-03 | 246 | 201 | 7 | EFO_0004284 | |
| Disease | coffee consumption measurement | 1.60e-03 | 182 | 201 | 6 | EFO_0006781 | |
| Disease | cervical carcinoma | 1.60e-03 | 182 | 201 | 6 | EFO_0001061 | |
| Disease | Polycystic Kidney, Autosomal Dominant | 1.61e-03 | 9 | 201 | 2 | C0085413 | |
| Disease | cortical thickness | CTTNBP2 HLA-B NCAM1 STAB1 PTPRF ATXN2 GLIS2 PKD1 FGFR3 FBXW10 NYAP2 FAT3 KIAA1614 ADAMTS7 VCAN KIAA1755 MACF1 | 1.68e-03 | 1113 | 201 | 17 | EFO_0004840 |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 1.75e-03 | 126 | 201 | 5 | EFO_0004611, EFO_0010351 | |
| Disease | smoking cessation | 1.82e-03 | 325 | 201 | 8 | EFO_0004319 | |
| Disease | Behcet's disease (is_implicated_in) | 1.88e-03 | 36 | 201 | 3 | DOID:13241 (is_implicated_in) | |
| Disease | cognitive function measurement | HFE HLA-B NCAM1 CHRNB1 STAB1 PTPRD PTPRF CLNK ARAP1 CNTN4 SEC16B DMXL2 NYAP2 NTRK3 GRIN2B THSD7B PLXNA4 MOGAT3 TNXB EPHA5 | 1.97e-03 | 1434 | 201 | 20 | EFO_0008354 |
| Disease | platelet component distribution width | GP6 LDLRAP1 HLA-B PTPRH ATXN2 C22orf31 NYAP2 VWF TADA1 MACF1 PKN2 ADPRHL1 TNXB | 2.12e-03 | 755 | 201 | 13 | EFO_0007984 |
| Disease | apolipoprotein A 1 measurement | HFE ABCA1 ACACB HLA-B LILRB2 PEX6 ADAR STAB1 ATXN2 SNX8 NYAP2 KANK4 MACF1 LILRA4 | 2.13e-03 | 848 | 201 | 14 | EFO_0004614 |
| Disease | cannabis dependence | 2.37e-03 | 135 | 201 | 5 | EFO_0007191 | |
| Disease | Hypercholesterolemia | 2.38e-03 | 39 | 201 | 3 | C0020443 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 2.38e-03 | 197 | 201 | 6 | EFO_0005680 | |
| Disease | Barrett's esophagus (is_implicated_in) | 2.44e-03 | 11 | 201 | 2 | DOID:9206 (is_implicated_in) | |
| Disease | beta-2 microglobulin measurement | 2.44e-03 | 11 | 201 | 2 | EFO_0005197 | |
| Disease | smoking behavior | 2.45e-03 | 341 | 201 | 8 | EFO_0004318 | |
| Disease | Alcoholic Intoxication, Chronic | 2.51e-03 | 268 | 201 | 7 | C0001973 | |
| Disease | lipoprotein measurement, phospholipid measurement | 2.75e-03 | 85 | 201 | 4 | EFO_0004639, EFO_0004732 | |
| Disease | Hematologic Neoplasms | 2.91e-03 | 12 | 201 | 2 | C0376545 | |
| Disease | hyperinsulinism (is_implicated_in) | 2.91e-03 | 12 | 201 | 2 | DOID:2018 (is_implicated_in) | |
| Disease | right ventricular stroke volume measurement | 2.91e-03 | 12 | 201 | 2 | EFO_0021817 | |
| Disease | Thromboembolism | 2.91e-03 | 12 | 201 | 2 | C0040038 | |
| Disease | Schizophrenia | ABCA1 HLA-B NCAM1 CSMD2 LILRB1 PTPRA ATXN2 VLDLR NTRK3 ITGA8 GRIN2B GRM2 NCAN TNXB | 3.06e-03 | 883 | 201 | 14 | C0036341 |
| Disease | sphingomyelin measurement | 3.07e-03 | 278 | 201 | 7 | EFO_0010118 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 3.13e-03 | 144 | 201 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | cognitive function measurement, self reported educational attainment | 3.13e-03 | 355 | 201 | 8 | EFO_0004784, EFO_0008354 | |
| Disease | Colorectal Carcinoma | ABCA1 ACACA PTPRD TOMM40L PTPRS ABCC8 SNX8 FGFR3 CNTN4 OVGP1 VRTN SMAD2 | 3.31e-03 | 702 | 201 | 12 | C0009402 |
| Disease | lipid measurement, lipoprotein measurement | 3.38e-03 | 90 | 201 | 4 | EFO_0004529, EFO_0004732 | |
| Disease | Disorder of eye | 3.42e-03 | 212 | 201 | 6 | C0015397 | |
| Disease | Connective Tissue Diseases | 3.43e-03 | 13 | 201 | 2 | C0009782 | |
| Disease | alcohol use disorder measurement | 3.58e-03 | 214 | 201 | 6 | EFO_0009458 | |
| Disease | interleukin 13 measurement | 3.58e-03 | 45 | 201 | 3 | EFO_0008171 | |
| Disease | platelet aggregation | 3.58e-03 | 45 | 201 | 3 | GO_0070527 | |
| Disease | urate measurement, bone density | CDR2 COL6A5 PTPRD GLIS2 CNTN4 LRRC4C PLXNA4 ANKRD11 KIAA1755 PRKDC TNXB | 3.63e-03 | 619 | 201 | 11 | EFO_0003923, EFO_0004531 |
| Disease | non-high density lipoprotein cholesterol measurement | HFE ABCA1 HLA-B PEX6 ATXN2 SNX8 OSGIN1 VLDLR NYAP2 CSF1R NCAN DMTN | 3.74e-03 | 713 | 201 | 12 | EFO_0005689 |
| Disease | Thrombus | 3.81e-03 | 46 | 201 | 3 | C0087086 | |
| Disease | total blood protein measurement | 3.83e-03 | 449 | 201 | 9 | EFO_0004536 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGIPGNVWSSISVED | 1186 | Q9UMD9 | |
| SPGIPVSVQTEESWL | 161 | Q7L0X2 | |
| NWPGTEFSLPTTGVL | 46 | Q96DZ1 | |
| TSSPVIGELWSPDQT | 486 | Q86XL3 | |
| PGSILSFETTTLWPI | 1036 | Q4VNC0 | |
| VVAVTAVDPDTGPWG | 491 | Q96JP9 | |
| TAVPAVQTDWATSPI | 76 | Q9N2K0 | |
| SVWVPAPSSAVAASG | 436 | Q6ZTN6 | |
| QSEPWGLIAPSVLAA | 251 | P0C6C1 | |
| LVAWNTVSTGLVPPA | 21 | Q9UJX6 | |
| SLIGGTSENPVSWPV | 1961 | Q6UB99 | |
| TSENPVSWPVGSDLL | 1966 | Q6UB99 | |
| LWFTGASLPAPVISS | 266 | Q7Z408 | |
| VEAGVVPWLSPQTSE | 2986 | P13611 | |
| TSVTSEPTRAPIWGD | 281 | Q8N5R6 | |
| APATTLSTTIEPWGL | 1056 | Q8IUX7 | |
| IPPTTAGWEESETET | 1071 | Q8IUX7 | |
| LLGTPTEETWPGVTA | 356 | Q07002 | |
| TSVFLEWIPPADTGG | 371 | P54756 | |
| EGLTLDTSLIPWASP | 476 | Q14416 | |
| RPQTEITDVWGPSIS | 836 | Q5XX13 | |
| AGEEEWTTAPVPQTI | 1431 | O95477 | |
| TPFSVGWQAVSTVPE | 636 | Q8IWV2 | |
| VVVSSDGSVRWQPPG | 131 | P11230 | |
| SSIVAQTAGIPTLPW | 246 | Q13085 | |
| PVADSSPAGAKWTET | 31 | Q8IXM2 | |
| INAPAPATTSSWEVV | 51 | O95567 | |
| TFPPEALWVTVGLSV | 461 | Q5ZPR3 | |
| LTATDSIQLWAPPGD | 126 | Q8TDJ6 | |
| SVDGTPSLPVSLSWV | 1241 | Q8TDJ6 | |
| EGWTGPLCTVPVSTS | 241 | Q9NYJ7 | |
| PNVEGASESPSIWLL | 31 | Q96M95 | |
| LGPVDSELWPTVGVA | 1276 | Q9UKP4 | |
| SVALPTNLDVAGPTW | 156 | Q2M1V0 | |
| TPGTTWILTEPSTIA | 4841 | Q9HC84 | |
| ISSLWPTLPSGIEAA | 321 | P39900 | |
| LWAEPGSVIIQGSPV | 31 | Q8N149 | |
| QVPTLPWSGSGLTVE | 396 | O00763 | |
| VPRPQALSGSSVVWE | 236 | Q5SW96 | |
| SQPVIFGTSPAVSGW | 541 | P98082 | |
| KGVSWQSPPSVEETS | 5911 | Q8WXI7 | |
| WSEPSDPLQLLVSGV | 206 | P59901 | |
| VSSDPPATIIWTLNG | 1121 | Q15746 | |
| TVPIASIDIPSGWDV | 211 | Q8NCW5 | |
| VPVLGRVSWEEGAPS | 176 | Q9BZJ8 | |
| AAGTWRSAPVPVTTQ | 271 | Q9Y5V3 | |
| LPDSWASGHSVPVVT | 191 | Q9BUP3 | |
| TPLIVEPSGWLTTNS | 181 | Q8N387 | |
| SPLPDVDWIVTGLQS | 236 | Q16288 | |
| SPWILASTTEGAPSV | 371 | Q12866 | |
| ITPSWSPGSDVTLLA | 396 | Q8N307 | |
| PLLLVSTTEGAWEAP | 591 | Q5JYT7 | |
| APGSSLVDPQISLWV | 101 | Q8TBE3 | |
| ATGEPTPTIEWLQAG | 4326 | Q8NDA2 | |
| WPEVEVPLNGTLSLS | 71 | O95998 | |
| GTWSSVVSGVPRLSP | 671 | Q99700 | |
| STATPAVGAWLVPID | 2031 | Q2LD37 | |
| LITSWGHDPGVVPTS | 571 | Q658Y4 | |
| ASPVEGTSAVEWSGP | 26 | Q5VZ46 | |
| APWTSTSVGFVAVGP | 86 | O95202 | |
| VTIWAANAGVTASPP | 496 | P20700 | |
| ANAGVTASPPTDLIW | 501 | P20700 | |
| VSESIPALGWIAVSP | 136 | P40123 | |
| SSPILSSTIPDFWGL | 811 | Q5VYM1 | |
| SPVQWPLSLVVGDTS | 21 | B1ANH7 | |
| PLSLVVGDTSTRWPQ | 26 | B1ANH7 | |
| QDEWTPGTAVLTSPV | 506 | Q9UIS9 | |
| WSAPSDPLELVVTGT | 191 | Q9HCN6 | |
| VSTPVLWTPGTAQIG | 326 | Q06265 | |
| EPEWSIVSGNTPIAV | 1046 | Q9HCM2 | |
| PAAVRGTTWPSAVVT | 5196 | Q7Z5P9 | |
| PPGTWLLTATASDLD | 256 | Q9Y5G4 | |
| ESTLWSSLSPPGLEA | 426 | Q13608 | |
| GVPPVQVFWESTGRT | 406 | Q14999 | |
| PGTVISFVTHPWDVS | 496 | Q9NUL7 | |
| IAGSTELLVTWQPGP | 331 | Q6UWB1 | |
| ELWVTASTIAGQGPP | 486 | Q6UWB1 | |
| FSPEWAALAITVPIT | 951 | O94854 | |
| LWAEPDSVITQGSPV | 31 | Q8N423 | |
| IGAAPLRPVSTSSSW | 96 | Q8N3J3 | |
| TTPAVSWGDAPTEVV | 1316 | Q9ULI4 | |
| VGPTPVVDWETTNVT | 476 | Q9HCJ2 | |
| SAASSPEALAPGWVV | 496 | Q9BZE0 | |
| IWEPSPSGTLVIGVI | 296 | Q30201 | |
| KAQEWDGTPGTPVVT | 576 | Q9P242 | |
| LRWEPSSQSTVPIVG | 296 | P01889 | |
| SLTGWTLVEVPARAP | 166 | Q9Y5Y3 | |
| GPSTISDTILEVGWP | 831 | P53708 | |
| PTSPSGVEEWIVTQV | 691 | P16112 | |
| TSWGLLPFAVPITTV | 276 | Q86VF5 | |
| SISISWSEPAVITGP | 1596 | Q9UMZ3 | |
| TSITITWDSGNPDPV | 346 | Q13332 | |
| SPPLWATASVSVEVA | 431 | Q9Y5I2 | |
| TTSGGEWPQILVFPE | 206 | Q7L5N7 | |
| VATWGISGTPAPLDS | 11 | P04070 | |
| GSTLSPWGEVLTPLA | 596 | Q4G163 | |
| PWGEVLTPLASSSVT | 601 | Q4G163 | |
| PSAVAATFTETWPGS | 21 | Q5W5W9 | |
| WTPDLEITSSQPLDG | 591 | B2RXH4 | |
| DWTAEGRLVPTTVPS | 681 | B2RXH4 | |
| LWTVPVSVPGGTRQS | 51 | P35218 | |
| AGSLTTPPLTESVTW | 231 | P35218 | |
| PPEVSVIWTFINGSG | 401 | P07333 | |
| PAVTTGPRTLSGVSW | 586 | A4D2P6 | |
| WEPTLVPELSLAGSV | 646 | Q9P2K1 | |
| ELAWTQEAPVSSGPL | 726 | Q5SW24 | |
| IAEEPSPSLGQTLEW | 26 | A1L168 | |
| IPVESSDIVPTWDGI | 1011 | P55265 | |
| GPTEAAGAWVTPELA | 456 | Q8IVS8 | |
| VLGVPTEDTWPGVSK | 316 | Q96Q40 | |
| TLTPWLAPIVSEGTF | 81 | Q8N5D6 | |
| SEPVASGWELASVNP | 396 | Q01850 | |
| SGWELASVNPEPVSS | 401 | Q01850 | |
| LATSQVGAWPAATPG | 631 | Q8WZ74 | |
| WPGSEVAINGSFPSI | 271 | O14638 | |
| PSATIGALSESLWPI | 256 | Q9UBR1 | |
| IIWTETLADQSPGPG | 11 | A8TX70 | |
| SDPPGEVVAVLSTWD | 2936 | Q8TDW7 | |
| PATWGPSVEQAADSL | 356 | Q92949 | |
| LVLSPGEWPVSDNTI | 46 | Q8NDY3 | |
| VDGSLSPQWTTAEPT | 276 | Q02246 | |
| PSDSEVTWNITVPDG | 41 | P48740 | |
| WSPVVPREASLGTQE | 91 | Q5T7N3 | |
| PTSAVWVAGPKITEN | 291 | Q9ULL0 | |
| FTGSSLELGPWSPEV | 296 | Q9HBE5 | |
| PTVWVKDGTGLVPSE | 71 | P22607 | |
| FRTLGTPDEVVWPGV | 216 | P24941 | |
| IQGDTALITRPWSPA | 81 | O95865 | |
| PDGKVVGAWDPTVSV | 151 | Q96SL4 | |
| WVVEENRTTVPGAPS | 136 | Q8NI29 | |
| VPSNWTLEEAASVPV | 1636 | P49327 | |
| SPEVWADSRSPGIIS | 96 | Q08495 | |
| TGTPDSTAPITIWRS | 206 | Q8NCQ7 | |
| STAPITIWRSESPTG | 211 | Q8NCQ7 | |
| GGSRSELVITWDPVP | 711 | Q9P232 | |
| GSPTTAVATVSIWSP | 151 | O43186 | |
| AVATVSIWSPASESP | 156 | O43186 | |
| AIDRATISPWPGTTL | 371 | Q8NC60 | |
| LWAEPGSVITQGSPV | 31 | Q8N6C8 | |
| AVVTAVEWGTPDPSS | 196 | Q9UJX0 | |
| GTLSWPDLLSDPSIV | 3416 | P98161 | |
| SIGITISPNGTWLPD | 96 | P18433 | |
| GLTTSTTELAWDPPV | 926 | P10586 | |
| AWTTDSKILPPGGEA | 416 | Q12889 | |
| ATSITLTWDSGNPEP | 336 | P23468 | |
| FTTWSTPGDAPVINL | 106 | Q6NXP2 | |
| PVTTTAPWASLGLSA | 16 | Q9UNW8 | |
| RDVAWAPSIGLPTST | 216 | P55735 | |
| SQWTEVLGSVGVPTP | 531 | O15211 | |
| QTHTPGWVSDPLVLG | 41 | Q9HCN2 | |
| ELSAVAGVVLSPNWP | 631 | Q9BYH1 | |
| SAIGSDTTPLPSWAA | 261 | Q9Y5X2 | |
| TATVDVAWAQSTPLP | 366 | Q6IEE7 | |
| QILVSTPDGAGSLPW | 71 | Q96BN2 | |
| LITSWGHDPGVVPTS | 216 | P0C866 | |
| LWAEPGSVITQGSPV | 31 | O75019 | |
| GWSEPSDPLELVVTG | 106 | O75019 | |
| LWAEPGSVITQGSPV | 31 | Q8NHL6 | |
| SSVESPGDPLIETFW | 551 | Q8IVG5 | |
| LTDNPTWIIDPIDGT | 81 | P29218 | |
| IWSLAETATSPDGAP | 316 | P78414 | |
| SPDDVASPQGDWTVV | 1326 | Q9H6K5 | |
| VLESTTVWPLAAEPG | 841 | Q9BQS7 | |
| STVTPAPSDASGIWE | 831 | O14594 | |
| APWIEIFLGNSTPST | 281 | Q6ZNE9 | |
| SGTWEQPRVDGLPVV | 31 | A0A1B0GW64 | |
| LPWEVSAGQVPDGST | 11 | Q86WV5 | |
| INVSWEVSGGPPALI | 126 | B1ATL7 | |
| PSEWGLPTSASEVAT | 201 | O95785 | |
| ATSVALPGWSPSETR | 351 | Q16513 | |
| PSPCLWVGTTLGTVL | 811 | Q5T5C0 | |
| TEVWGIPSPIDTVFT | 1186 | Q92954 | |
| VISSSVPWSASPGDR | 731 | P63128 | |
| FTWTPDGIPTLSNIT | 686 | Q09428 | |
| GSTPVTPVIKAGWLD | 321 | Q96P48 | |
| NSWSEAPLPGSLLDV | 981 | Q0VD83 | |
| PLDTRTSISIGQPTW | 111 | Q7Z7G1 | |
| SSGISISWISAPLPV | 111 | Q8WZ69 | |
| ASGDPIPSITWRTST | 331 | P13591 | |
| ILWLSVGSSGDAPPT | 16 | Q53H76 | |
| PKVLVWVTDGGSSDP | 136 | Q6PCB0 | |
| SGNVPSSPEEVEAVW | 546 | Q9UNS1 | |
| PTQEDWLVSVLPEGS | 101 | Q9NQW7 | |
| VGDIVAAPLPTNGSW | 356 | Q9Y2W6 | |
| GSITTIDVPWNVVPE | 1736 | P04275 | |
| QTVPGETPVLTSAWE | 166 | Q4G0A6 | |
| QSPVSGVTDIWPVGV | 1771 | Q15772 | |
| PTVWVSVPIAEGESD | 991 | Q9Y5Y9 | |
| TIPSTCSEIWGLSTP | 76 | Q15796 | |
| TGAVVSRPVTWQGPL | 106 | Q9BRG2 | |
| AVGAWGLSEPSPVSE | 631 | Q96MS0 | |
| TDITPDSVGLSWTVP | 1586 | P22105 | |
| PDSLSLSWTVPEGQF | 2316 | P22105 | |
| PDSLSLSWTVPEGQF | 2641 | P22105 | |
| ATPDSVGLSWTVPEG | 3366 | P22105 | |
| EGPVTAVIPTWQALT | 276 | Q9Y2I1 | |
| PLASITTAWGPEGAI | 3056 | Q6ZS81 | |
| EWTVAGSGAPVAPVT | 1786 | O15015 | |
| SIPLVSLDIPSGWDA | 221 | A6XGL0 | |
| QTEDSWVPASPDTGL | 91 | Q8N5L8 | |
| VWGSPVTETQPLSLG | 66 | C9JH25 | |
| EITDSAGVVLSPNWP | 596 | Q53EL9 | |
| IISDAGPDNSSWAPV | 2416 | Q9NY15 | |
| SWAPVAPGTVVVSRI | 2426 | Q9NY15 | |
| PPGLWATVGSQEETA | 271 | A0A0J9YWL9 | |
| SWSLPVTVDLPGDAV | 271 | P40238 | |
| WGVFSSGESPAIVPD | 1456 | O43151 | |
| VSVEETPGWPTTLLV | 461 | P40126 | |
| PSETLTPLVTWGAGI | 276 | O95427 | |
| LLVEFPATGGVIPSW | 441 | Q13563 | |
| VVEFPATGGAIPSWQ | 321 | Q9P0L9 | |
| LTDEDWPVLSSGTPN | 411 | Q96JE7 | |
| WPVLSSGTPNLLTGE | 416 | Q96JE7 | |
| WTGLATPTGVPKDEV | 2196 | P78527 | |
| DSIVPVVLSADPGTW | 511 | Q9UJ78 | |
| WQLSPTEVFPTVVGD | 86 | Q969M1 | |
| ETSPWGPCSEDTLVT | 666 | Q9C0I4 | |
| TPQLASVGEGAVIPW | 461 | Q9H8Y1 | |
| IILSPGISDATAPAW | 131 | Q96RJ3 | |
| TNSSIALTWEVPDGP | 131 | Q9HD43 | |
| VPEEAISPGVTASWI | 221 | P40818 | |
| AGPLASAESLEPVSW | 866 | Q63HR2 | |
| FTTLGEVAPVWVPDS | 686 | O95405 | |
| AISSGTWVDIAPLLP | 316 | O94874 | |
| PLLVGTPGSWQSTID | 131 | Q6UXV3 | |
| VVSNRVPIPWVSGTS | 461 | O14773 | |
| VSEVSVPPKGTSAAW | 786 | P98155 | |
| SDIWSVDPSSVGSSP | 956 | Q96L42 | |
| SSVPVWSGVNIAGVP | 196 | Q6ZMR3 | |
| SESPSIFWVLPDGSI | 506 | Q9NR99 | |
| RPSAPWTGQIIVTEE | 616 | P52179 | |
| TEELIAGSTGPWESP | 656 | Q8NFW9 | |
| WIVPSLVAGDTDTVP | 256 | Q13224 |